Asthma and opportunity respiratory infection

ASTHMA_OPPORTUNIST_INFECTIONS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions J10_ASTHMA	70209
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints MYCOBLUNGATYPICA ABPA J10_BRONCHIECTASIS	1984
6. Filter based on genotype QC (FinnGen only)	1783

Control definitions (FinnGen only)

Control conditions: not J10_ASTHMA

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	ASTHMA_OPPORTUNIST_INFECTIONS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS	!J10_ASTHMA
SEX
INCLUDE	MYCOBLUNGATYPICA\|ABPA\|J10_BRONCHIECTASIS
PRE_CONDITIONS
CONDITIONS	J10_ASTHMA
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Asthma and opportunity respiratory infection based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	8980	5319	3578
Only index persons	7807	4794	3013
Unadjusted period prevalence (%)
Whole population	0.13	0.15	0.10
Only index persons	0.15	0.18	0.12
Median age at first event (years)
Whole population	63.65	63.39	64.10
Only index persons	63.61	63.28	64.15

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1783	1087	696
Unadjusted period prevalence (%)	0.36	0.39	0.32
Median age at first event (years)	63.49	61.86	66.02

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1831: Matched controls
18310

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

9.8

316.7

415

530

H02AB04

ATC

methylprednisolone; systemic

6.8

311.3

630

1303

R96

ICPC

Asthma

21.3

307.7

631

442

R03BA02

ATC

budesonide; inhalant

12.7

307.7

860

1197

J01MA14

ATC

moxifloxacin; systemic

13.6

307.7

719

832

R03BA05

ATC

fluticasone; inhalant

15.0

307.7

977

1300

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

18.1

307.7

302

198

R03DC03

ATC

montelukast; oral

30.5

307.7

1134

927

R03BA08

ATC

ciclesonide; inhalant

14.2

307.7

513

488

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

12.5

307.7

350

340

J45

ICD-10 Finland

Asthma

30.6

307.7

677

344

R03DA04

ATC

theophylline; systemic, rectal

30.4

307.7

550

255

R03BB04

ATC

tiotropium bromide; inhalant

39.9

307.7

1108

678

J45.0

ICD-10 Finland

Predominantly allergic asthma

228.3

307.7

785

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

8.1

307.7

526

868

J18.9

ICD-10 Finland

Pneumonia, unspecified

8.8

307.7

1215

3362

J46

ICD-10 Finland

Status asthmaticus

215.4

307.7

363

XG474

NOMESCO Finland

Exhalation nntrogen oxide

36.0

307.7

222

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

7.4

307.7

599

1129

R03AC13

ATC

formoterol; inhalant

28.4

307.7

394

175

J45.8

ICD-10 Finland

Mixed asthma

361.6

307.7

351

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

13.6

307.7

379

344

UGC12

NOMESCO Finland

Flexible bronchoscopy

15.2

307.7

702

721

R03AK11

ATC

formoterol and fluticasone; inhalant

41.5

307.7

267

R03AK07

ATC

formoterol and budesonide; inhalant

8.7

307.7

821

1568

R03AC03

ATC

terbutaline; inhalant

9.6

307.7

621

927

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

118.1

307.7

1519

725

R03AK06

ATC

salmeterol and fluticasone; inhalant

32.4

307.7

1109

829

J47

ICD-10 Finland

Bronchiectasis

1074.8

307.7

1603

119

R03BA01

ATC

beclometasone; inhalant

13.4

307.7

750

900

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

15.4

307.7

351

277

R03AC02

ATC

salbutamol; inhalant

33.2

307.7

1735

6450

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

9.4

307.7

592

890

R03AC12

ATC

salmeterol; inhalant

59.4

307.7

531

125

A31.0

ICD-10 Finland

Pulmonary mycobacterial infection

141.2

307.7

190

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

8.0

307.7

919

2040

J45.9

ICD-10 Finland

Asthma, unspecified

306.9

307.7

1623

454

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

23.4

307.7

336

174

J45.1

ICD-10 Finland

Nonallergic asthma

415.3

307.7

872

R03BB01

ATC

ipratropium bromide; inhalant

17.1

307.7

327

230

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

37.1

307.7

412

142

R03AK08

ATC

formoterol and beclometasone; inhalant

55.0

307.7

502

125

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

18.0

307.7

578

457

H02AB06

ATC

prednisolone; systemic

17.3

307.7

1638

6036

H02AB07

ATC

prednisone; oral

6.6

295.4

614

1297

R03DC01

ATC

zafirlukast; oral

46.8

294.4

174

J01FA06

ATC

roxithromycin; oral

5.8

285.7

1253

5011

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

45.8

274.6

163

J01MA12

ATC

levofloxacin; systemic

5.3

260.2

778

2244

TDM10

NOMESCO Finland

Puncture of maxillary antrum

13.8

259.7

254

211

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

64.5

258.8

143

TGC00

NOMESCO Finland

Bronchial lavation

14.5

251.4

238

187

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

11.0

248.9

286

303

51899

ICD-8 Finland

Bronchiectasis

105.8

248.4

128

R03AK03

ATC

[U] fenoterol and ipratropium bromide

9.9

240.9

300

354

GD1AD

NOMESCO Finland

Thorax CT examination

7.5

233.0

383

627

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

5.4

232.4

1387

6693

R04.2

ICD-10 Finland

Haemoptysis

11.0

224.7

256

267

GD1AA

NOMESCO Finland

Thorax X-ray examination

5.4

217.6

1436

7337

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

7.6

208.5

331

519

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

12.0

204.5

216

201

R01AD08

ATC

fluticasone; nasal

4.3

200.3

823

2935

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

11.6

200.1

217

210

J01FA09

ATC

clarithromycin; systemic

4.2

197.1

902

3465

49300

ICD-8 Finland

Asthma, bronchiale

+∞

195.4

184

XG410

NOMESCO Finland

Flow-volume spirometry

9.8

194.3

240

278

J01FA10

ATC

azithromycin; systemic

4.7

192.9

1364

7063

R06.0

ICD-10 Finland

Dyspnoea

4.0

187.0

891

3493

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

7.2

182.7

302

492

R02

ICPC

Shortness of breath/dyspnoea

4.7

181.9

542

1506

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

52.4

181.1

104

UDH02

NOMESCO Finland

Rhinopharyngoscopy

6.7

172.4

305

532

R81

ICPC

Pneumonia

8.7

169.0

229

297

J01FA15

ATC

telithromycin; oral

5.6

169.0

375

811

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

19.1

168.9

135

J32.4

ICD-10 Finland

Chronic pansinusitis

25.2

163.7

116

R05

ICD-10 Finland

Cough

3.9

163.5

703

2527

R01AD09

ATC

mometasone; nasal

3.6

159.7

1096

5313

J20

ICD-10 Finland

Acute bronchitis

5.0

158.1

399

961

J01AA02

ATC

doxycycline; systemic

10.7

153.4

1743

11870

XQ800

NOMESCO Finland

Prick test

6.6

147.7

258

442

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

7.6

143.3

218

322

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

8.8

139.9

184

229

R01AD05

ATC

budesonide; nasal

5.5

131.3

284

594

A07AA02

ATC

nystatin; oral

5.6

130.5

273

554

R05

ICPC

Cough

3.3

130.4

730

3032

R01AD01

ATC

beclometasone; nasal

4.0

128.9

461

1432

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

+∞

123.3

117

A01AB09

ATC

miconazole; local oral

4.7

121.2

325

812

XG405

NOMESCO Finland

Education on PEF monitoring

18.9

118.9

J01.0

ICD-10 Finland

Acute maxillary sinusitis

3.3

115.2

611

2428

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

8.6

115.2

153

192

R03BC03

ATC

nedocromil; inhalant

5.3

115.0

256

547

J96.1

ICD-10 Finland

Chronic respiratory failure

10.1

114.9

134

142

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

8.4

114.1

154

197

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

7.5

113.3

170

246

J33.0

ICD-10 Finland

Polyp of nasal cavity

9.6

112.1

136

152

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

11.1

110.4

120

115

J31.0

ICD-10 Finland

Chronic rhinitis

4.7

108.2

282

686

R06AE07

ATC

cetirizine; oral

2.9

106.4

992

5335

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

2.9

105.5

978

5237

J42

ICD-10 Finland

Unspecified chronic bronchitis

15.3

103.8

WW200

NOMESCO Finland

Immunization

8.7

103.1

135

166

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

54.4

101.7

R01AD58

ATC

fluticasone, combinations; nasal

3.1

99.5

560

2277

J01MA02

ATC

ciprofloxacin; systemic

2.8

98.7

986

5429

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

46.0

98.2

R06.2

ICD-10 Finland

Wheezing

6.8

98.1

161

256

R03BB07

ATC

umeclidinium bromide; inhalant

23.0

97.3

J41.1

ICD-10 Finland

Mucopurulent chronic bronchitis

42.8

96.5

A03

ICPC

Fever

3.4

94.9

431

1539

Z3231

NOMESCO Finland

Registered nurse

2.8

92.6

703

3340

4940A

ICD-9 Finland

Bronchiectasis[BRONCHIECTASIAE]

168.7

92.1

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

2.8

91.5

648

2967

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

49.6

91.2

R01BA52

ATC

pseudoephedrine, combinations; oral

2.7

86.6

714

3514

R01AD12

ATC

fluticasone furoate; nasal

2.7

84.2

657

3138

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

+∞

82.9

H02AB09

ATC

hydrocortisone; systemic

7.8

82.5

117

158

R28

ICPC

Limited function/disability (R)

10.7

80.5

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

7.7

80.3

115

157

Z3226

NOMESCO Finland

Physiotherapist

2.9

80.2

500

2119

R06AX27

ATC

desloratadine; oral

2.7

79.8

595

2765

J33.8

ICD-10 Finland

Other polyp of sinus

10.8

79.4

R03AL11

ATC

formoterol, glycopyrronium bromide and budesonide; inhalant

20.6

78.6

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

4.0

78.5

249

696

B44.1

ICD-10 Finland

Other pulmonary aspergillosis

404.3

78.5

R03BC01

ATC

cromoglicic acid; inhalant

16.7

78.2

R95

ICPC

Chron obstructive pulmonary disease

6.5

77.1

130

212

Z01.8

ICD-10 Finland

Other specified special examinations

2.7

76.7

591

2783

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.8

76.2

263

779

R03BB02

ATC

oxitropium bromide; inhalant

23.6

76.1

J01DA06

ATC

[U] cefuroxime

3.1

74.8

385

1462

J01CA04

ATC

amoxicillin; systemic

3.5

72.8

1602

12242

R05CB01

ATC

acetylcysteine; inhalant, oral

10.0

72.3

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.4

70.5

923

5492

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

13.7

70.2

A02BC05

ATC

esomeprazole; systemic

2.4

69.6

925

5532

C03CA01

ATC

furosemide; systemic

2.4

69.1

837

4804

R50.9

ICD-10 Finland

Fever, unspecified

2.8

68.1

408

1677

A01AB04

ATC

amphotericin B; local oral

4.5

66.5

175

424

4730A

ICD-9 Finland

Chronic sinusitis, Maxillary

9.6

66.1

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.0

65.7

349

1342

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

5.4

65.2

133

260

J01DA08

ATC

[U] cefaclor

3.5

65.1

247

776

J01GB01

ATC

tobramycin; inhalant, parenteral

333.5

64.9

J02AC01

ATC

fluconazole; systemic

2.3

63.4

821

4801

SPAT1325

SPAT

Vaccination

2.3

63.4

819

4785

XF400

NOMESCO Finland

ECG with 12 standard connections

2.6

62.1

435

1928

C01CA24

ATC

epinephrine; parenteral

4.5

62.1

161

385

4931A

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]

+∞

61.8

J01DC02

ATC

cefuroxime; systemic

4.4

61.6

162

392

R74

ICPC

Upper respiratory infection acute

2.4

61.3

613

3202

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

11.8

60.5

R4110

NOMESCO Finland

Physiotherapy

2.3

60.4

676

3702

R06AX13

ATC

loratadine; oral

2.9

59.3

323

1254

A02BC02

ATC

pantoprazole; systemic

2.5

58.5

1436

10799

ZXA10

NOMESCO Finland

Bilateral

2.5

57.7

493

2392

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

+∞

57.6

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.2

57.5

714

4064

J15.8

ICD-10 Finland

Other bacterial pneumonia

14.4

57.2

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

7.1

57.1

127

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

6.7

57.0

146

R29

ICPC

Respiratory symptom/complaint other

3.6

56.0

203

617

J01DB01

ATC

cefalexin; oral

3.0

55.8

1598

12756

R05DA20

ATC

opium alkaloids and derivatives - combinations

2.3

55.6

569

2981

UDQ12

NOMESCO Finland

Flexible laryngoscopy

3.8

55.5

180

507

R78

ICPC

Acute bronchitis/bronchiolitis

6.9

55.0

129

50301

ICD-8 Finland

Chronic sinusitis, Maxillaris NUD

10.5

54.8

R06AE09

ATC

levocetirizine; oral

2.8

54.5

310

1229

R06AX26

ATC

fexofenadine; oral

3.9

53.9

166

451

XG466

NOMESCO Finland

Sleep oxymetry

5.6

52.9

104

196

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.4

52.8

449

2163

M05BA04

ATC

alendronic acid; oral

2.8

52.8

306

1224

R06AX22

ATC

ebastine; oral

2.6

52.7

365

1597

49099

ICD-8 Finland

Bronchitis, unspecified

12.8

52.2

A02BC01

ATC

omeprazole; systemic

2.2

51.8

634

3557

TPH04

NOMESCO Finland

Cathetrisation of vein

2.3

51.2

542

2864

N02AX02

ATC

tramadol; systemic, rectal

2.1

50.3

916

5956

4931B

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]

+∞

49.2

J01DA01

ATC

[U] cefalexin

2.1

49.1

1211

8775

J43.9

ICD-10 Finland

Emphysema, unspecified

7.4

48.9

101

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

21.0

48.8

49302

ICD-8 Finland

Asthma, Rhinitis allergica cum asthmate bronchiali

+∞

48.1

DHB20

NOMESCO Finland

Polypectomy of internal nose

8.7

47.9

Z2221

NOMESCO Finland

Medical doctor

2.2

47.7

591

3310

UDM02

NOMESCO Finland

Sinoscopy

6.1

47.1

141

G47.3

ICD-10 Finland

Sleep apnoea

2.3

47.0

473

2436

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

5.5

46.8

177

J32.9

ICD-10 Finland

Chronic sinusitis, unspecified

9.9

46.7

S01GX01

ATC

cromoglicic acid; ophthalmic

2.4

46.7

403

1943

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

4.3

46.2

125

308

4222

FHL

Endonasal etmoidectomy

16.9

45.4

DPA25

NOMESCO Finland

Trephine of frontal sinus through nose

15.1

45.2

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

8.4

45.1

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.5

44.5

314

1378

DMB00

NOMESCO Finland

Endonasal trephine of maxillary antrum

12.9

44.4

A02BC03

ATC

lansoprazole; oral

2.1

44.3

646

3827

J01FF01

ATC

clindamycin; systemic

2.1

44.2

581

3312

J15.1

ICD-10 Finland

Pneumonia due to Pseudomonas

120.5

43.9

R24

ICPC

Haemoptysis

11.8

43.9

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

6.1

43.9

130

4779A

ICD-9 Finland

Allergic rhinitis, Cause unspecified

14.7

43.4

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.3

43.3

391

1916

R05FB02

ATC

cough suppressants and expectorants; systemic

2.0

43.0

795

5110

R99

ICPC

Respiratory disease other

5.9

42.9

140

R5140

NOMESCO Finland

Monitoring the use of the aid

2.6

42.2

270

1128

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

4.5

41.3

103

238

DPA30

NOMESCO Finland

Sphenotomy

16.2

41.0

H65.3

ICD-10 Finland

Chronic mucoid otitis media

6.8

41.0

J30.3

ICD-10 Finland

Other allergic rhinitis

5.1

40.8

180

GD1AA, ,

SPAT

2.5

40.6

304

1368

1240

FHL

Bronchoscopy

8.6

40.5

J01XB01

ATC

colistin; inhalant, parenteral

406.2

40.3

R01AD11

ATC

triamcinolone; nasal

2.9

40.2

201

737

4912B

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]

16.5

40.1

120

Kela drug reimbursment

Hypogammaglobulinaemia

77.0

40.1

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

13.4

40.0

H65.2

ICD-10 Finland

Chronic serous otitis media

7.3

40.0

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

90.2

39.9

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.9

39.8

209

787

J37.0

ICD-10 Finland

Chronic laryngitis

4.3

39.5

105

255

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

6.8

37.9

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

199.1

37.9

A02BA02

ATC

ranitidine; systemic

2.1

37.6

455

2491

SPAT1254

SPAT

Administration of medicine

2.2

37.3

361

1810

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

9.0

37.3

B90.9

ICD-10 Finland

Sequelae of respiratory and unspecified tuberculosis

14.6

36.6

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

5.1

36.4

155

R05FA02

ATC

opium derivatives and expectorants; systemic

1.9

36.1

798

5353

J98.1

ICD-10 Finland

Pulmonary collapse

10.5

36.1

WZC30

NOMESCO Finland

Teaching

2.2

36.0

382

1985

E0000UV, ,

ATC

1.9

35.6

817

5538

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

35.6

634

3965

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.8

35.3

846

5810

Z71.8

ICD-10 Finland

Other specified counselling

1.9

35.2

662

4211

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.2

34.9

360

1848

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

6.3

34.9

J01DC04

ATC

cefaclor; oral

8.0

34.6

R49.08

ICD-10 Finland

Other specified dysphonia

4.9

34.6

162

N03AX16

ATC

[U] pregabalin

2.0

34.2

498

2903

A46

ICD-10 Finland

Erysipelas

2.2

34.1

351

1799

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

9.1

33.4

4224

FHL

Endonasal anthrostomy

9.7

33.3

Z2446

NOMESCO Finland

Social worker

3.0

33.2

157

557

C07AB07

ATC

bisoprolol; oral

1.8

33.0

1057

7865

R05CA10

ATC

expectorants - combinations

5.0

32.7

150

R03AK

ATC

Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics

49.7

32.6

R03AC18

ATC

indacaterol; inhalant

10.5

32.5

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.0

32.5

438

2479

ZXE00

NOMESCO Finland

One hour or less

1.8

32.2

750

5064

WX892

NOMESCO Finland

Monitored bed care

2.6

32.1

196

796

N02BE01

ATC

paracetamol; systemic, rectal

2.9

32.0

1698

14950

B05XA03

ATC

sodium chloride; parenteral

167.9

31.8

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

4.0

31.7

234

J01FA01

ATC

erythromycin; systemic

2.3

31.3

255

1184

I50.9

ICD-10 Finland

Heart failure, unspecified

2.1

31.2

365

1958

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

3.0

31.0

146

516

SPAT1255

SPAT

Intravenous administration of medicine

2.7

30.8

179

709

4226

FHL

Posterior radical surgery and possible etmoidectomy

9.6

30.7

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

4.2

30.1

207

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

30.0

468

2773

J96.0

ICD-10 Finland

Acute respiratory failure

6.1

29.6

Z3229

NOMESCO Finland

Other healthcare associate professional

2.5

29.5

202

866

J02AC03

ATC

voriconazole; systemic

32.3

29.1

SPAT1058

SPAT

PEF monitoring instruction

2.6

29.0

176

711

R01AC01

ATC

cromoglicic acid; nasal

4.1

29.0

204

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.3

28.8

235

1090

L28

ICPC

Limited function/disability (L)

1.9

28.7

471

2832

R49.01

ICD-10 Finland

Functional dysphonia

4.0

28.4

216

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

4.4

28.3

169

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.0

28.2

365

2025

46100

ICD-8 Finland

Acute sinusitis, Maxillaris

6.1

28.2

R09.3

ICD-10 Finland

Abnormal sputum

6.2

28.1

Y0499

ICD-8 Finland

Investigation of respiratory system

7.6

28.1

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

78.9

27.8

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

33.3

27.8

48609

ICD-8 Finland

Pneumonia, unspecified

6.9

27.7

SPAT1263

SPAT

Sampling

1.7

27.3

804

5729

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.8

27.2

566

3654

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.3

27.2

231

1089

R03DX09

ATC

mepolizumab; parenteral

+∞

27.1

3028

Kela drug reimbursment

Mepolizumab

+∞

27.1

R05CB03

ATC

carbocisteine; oral

4.4

27.1

162

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

27.0

910

6718

S81.0

ICD-10 Finland

Open wound of knee

5.7

27.0

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

26.9

676

4604

SPAT1059

SPAT

Spirometry at the office

3.1

26.9

114

379

R05CB02

ATC

bromhexine; systemic

5.4

26.9

100

B37.0

ICD-10 Finland

Candidal stomatitis

7.0

26.8

A31.9

ICD-10 Finland

Mycobacterial infection, unspecified

142.1

26.7

ZXD10

NOMESCO Finland

Scheduled procedure

1.7

26.7

735

5134

J32.2

ICD-10 Finland

Chronic ethmoidal sinusitis

9.5

26.2

M05BA07

ATC

risedronic acid; oral

3.3

26.1

103

328

4939A

ICD-9 Finland

Asthma, unspecified[ASTHMA ALIA DEFINITA SINE EXACERBATIONE]

+∞

26.1

297, ,

Kela drug reimbursment

+∞

26.1

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.0

26.1

313

1686

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

8.1

26.1

R83

ICPC

Respiratory infection other

1.9

25.9

380

2195

ZX120

NOMESCO Finland

Intravenous

2.3

25.7

221

1045

N03AX12

ATC

[U] gabapentin; oral

2.0

25.4

341

1909

R03DA54

ATC

theophylline, combinations excl. psycholeptics; systemic

6.5

25.2

R03CC02

ATC

salbutamol; systemic

3.9

25.1

194

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

3.9

25.1

194

RK110, ,

NOMESCO Finland

8.6

24.9

4711A

ICD-9 Finland

Nasal polyps, Polypoid sinus degeneration

39.4

24.9

R60.0

ICD-10 Finland

Localized oedema

2.0

24.9

305

1654

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

253.5

24.7

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

6.1

24.7

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.6

24.6

147

589

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

24.1

291

1569

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

3.3

24.0

303

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

23.8

495

3173

C08DA01

ATC

verapamil; systemic

2.9

23.8

115

412

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

4.9

23.7

108

B44.8

ICD-10 Finland

Other forms of aspergillosis

243.0

23.7

S97

ICPC

Chronic ulcer skin

2.4

23.6

168

731

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.0

23.6

269

1419

J01.1

ICD-10 Finland

Acute frontal sinusitis

5.5

23.6

ZXA05

NOMESCO Finland

Left side

1.8

23.6

510

3306

I45.9

ICD-10 Finland

Conduction disorder, unspecified

6.9

23.4

SPAT1057

SPAT

Peak expiratory flow measurement

4.9

23.2

106

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.9

23.2

110

390

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

23.2

266

1406

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

23.1

264

1393

S18

ICPC

Laceration/cut

1.6

23.1

936

7143

RK320, ,

NOMESCO Finland

8.1

23.0

SPAT1257

SPAT

Teaching of medicine inhalation technique

3.5

23.0

240

J86.9

ICD-10 Finland

Pyothorax without fistula

6.3

22.8

4660A

ICD-9 Finland

Acute bronchitis and bronchiolitis, Acute bronchitis

9.4

22.7

X59

ICD-10 Finland

Exposure to unspecified factor

1.9

22.7

357

2101

RF410, ,

NOMESCO Finland

6.0

22.6

A01AB10

ATC

natamycin; local oral

3.7

22.6

204

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

5.5

22.5

J05AH02

ATC

oseltamivir; oral

8.9

22.4

6BA02, ,

NOMESCO Finland

35.5

22.1

48509

ICD-8 Finland

Bronchopneumonia, unspecified

6.4

21.9

R03AC04

ATC

fenoterol; inhalant

39.1

21.7

L95

ICPC

Osteoporosis

2.6

21.7

134

545

XF600

NOMESCO Finland

Bloodpressure measurement

2.5

21.7

147

625

J01DA09

ATC

[U] cefadroxil

1.7

21.6

472

3058

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.6

21.6

127

505

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

21.4

653

4615

DHB50

NOMESCO Finland

Turbinoplasty

4.2

21.3

139

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

21.3

284

1579

RK250, ,

NOMESCO Finland

9.1

21.2

M05BX04

ATC

denosumab; parenteral

2.2

21.2

186

885

D80.8

ICD-10 Finland

Other immunodeficiencies with predominantly antibody defects

50.6

21.1

SPAT1260

SPAT

Consultation of another employee

1.8

21.1

357

2143

N05CF01

ATC

zopiclone; oral

1.6

21.1

641

4523

L17

ICPC

Foot/toe symptom/complaint

1.7

21.1

611

4260

49109

ICD-8 Finland

Chronic bronchitis, Unspecified

37.7

20.8

R09

ICPC

Sinus symptom/complaint

2.3

20.7

159

715

UJF32

NOMESCO Finland

Coloscopy

1.7

20.6

535

3621

49102

ICD-8 Finland

Chronic bronchitis, Purulenta

212.3

20.6

4610A

ICD-9 Finland

Acute sinusitis, Maxillary

6.4

20.6

J34.2

ICD-10 Finland

Deviated nasal septum

2.8

20.5

105

388

H72.0

ICD-10 Finland

Central perforation of tympanic membrane

4.1

20.5

139

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.9

20.4

301

1730

J20.0

ICD-10 Finland

Acute bronchitis due to Mycoplasma pneumoniae

7.5

20.4

R23.3

ICD-10 Finland

Spontaneous ecchymoses

3.9

20.3

158

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.6

20.1

705

5137

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.5

20.1

133

559

WX722

NOMESCO Finland

PEEP

2.8

20.1

107

404

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

3.0

20.1

320

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.2

19.9

186

907

ZXA00

NOMESCO Finland

Right side

1.7

19.9

533

3633

E000001, ,

ATC

1.8

19.8

349

2118

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

19.7

677

4902

R42

ICD-10 Finland

Dizziness and giddiness

1.7

19.6

487

3253

J01

ICD-10 Finland

Acute sinusitis

2.7

19.6

105

398

J18

ICD-10 Finland

Pneumonia, organism unspecified

6.1

19.5

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

4.5

19.5

110

M05BB03

ATC

alendronic acid and colecalciferol; oral

3.2

19.4

246

TPH07

NOMESCO Finland

Cathetrisation of artery

2.0

19.4

246

1343

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

6.4

19.3

348

Kela drug reimbursment

Roflumilast

26.3

19.1

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.1

19.1

192

963

R03AC19

ATC

olodaterol

20.3

19.1

M79.6

ICD-10 Finland

Pain in limb

1.6

19.0

813

6181

R01AD59

ATC

mometasone, combinations; nasal

2.6

19.0

110

434

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.5

19.0

119

488

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

2.1

19.0

196

994

A28

ICPC

Limited function/disability NOS

1.7

18.9

438

2868

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

3.2

18.9

235

R03DA05

ATC

aminophylline; systemic, rectal

8.2

18.8

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.4

18.6

138

611

ZY010

NOMESCO Finland

Hospital outpatient

2.9

18.6

323

B96.5

ICD-10 Finland

Pseudomonas (aeruginosa) as the cause of diseases classified to other chapters

38.8

18.6

D80.0

ICD-10 Finland

Hereditary hypogammaglobulinaemia

191.9

18.6

N06AB04

ATC

citalopram; systemic

1.7

18.5

373

2348

R04

ICPC

Breathing problem other

2.8

18.5

346

4900A

ICD-9 Finland

Bronchitis, not specified as acute or chronic[BRONCHITIS NUD]

15.2

18.4

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

18.4

543

3778

RF420, ,

NOMESCO Finland

5.0

18.3

A01

ICPC

Pain general/multiple sites

2.0

18.3

222

1192

P01AB01

ATC

metronidazole; oral, rectal

1.6

18.3

711

5278

R79

ICPC

Chronic bronchitis

17.8

18.2

L03

ICPC

Low back symptom/complaint

1.6

18.2

537

3736

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.0

18.0

220

1184

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

4.6

18.0

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

18.0

491

3347

A15.0

ICD-10 Finland

Tuberculosis of lung, confirmed by sputum microscopy with or without culture

33.2

18.0

F2680, ,

NOMESCO Finland

53.1

18.0

J41.0

ICD-10 Finland

Simple chronic bronchitis

7.3

17.8

WX002

NOMESCO Finland

Sedation and analgesia

1.7

17.8

391

2518

A03FA02

ATC

cisapride; oral, rectal

2.1

17.8

168

822

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

17.8

471

3185

D07AA02

ATC

hydrocortisone; topical

1.9

17.7

237

1315

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

17.7

409

2669

S81.9

ICD-10 Finland

Open wound of lower leg, part unspecified

5.2

17.7

E000007, ,

ATC

2.6

17.7

104

413

R4190

NOMESCO Finland

Nutritional therapy

3.0

17.7

282

J32.8

ICD-10 Finland

Other chronic sinusitis

14.7

17.6

J92.0

ICD-10 Finland

Pleural plaque with presence of asbestos

3.8

17.6

146

R75

ICPC

Sinusitis acute/chronic

2.7

17.5

362

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

24.3

17.3

R03BB05

ATC

aclidinium bromide; inhalant

21.1

17.3

A44

ICPC

General and Unspecified, Preventive immunization/medic

2.1

17.3

170

845

E88.0

ICD-10 Finland

Disorders of plasma-protein metabolism, not elsewhere classified

42.4

17.3

J34.8

ICD-10 Finland

Other specified disorders of nose and nasal sinuses

5.2

17.2

R11

ICD-10 Finland

Nausea and vomiting

2.0

17.2

188

972

N02AA05

ATC

oxycodone; systemic

1.7

17.1

412

2718

R03DX07

ATC

roflumilast; oral

31.8

17.0

4239

FHL

Other measure in this category

16.1

17.0

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

17.0

202

1076

Q32.21

ICD-10 Finland

Secondary congenital bronchomalacia

50.5

17.0

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

4.1

17.0

118

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.6

16.9

375

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.7

16.8

364

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

16.7

745

5668

J33.9

ICD-10 Finland

Nasal polyp, unspecified

5.1

16.7

Q89.34

ICD-10 Finland

Cartagena syndrome (immotile cilia)

+∞

16.7

DJD20

NOMESCO Finland

Plastic repair of septum of nose

3.1

16.7

237

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

16.6

245

1402

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.0

16.6

208

1128

B44.0

ICD-10 Finland

Invasive pulmonary aspergillosis

90.9

16.6

R53

ICD-10 Finland

Malaise and fatigue

1.6

16.4

478

3301

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.5

16.3

101

412

R01BA51

ATC

phenylpropanolamine, combinations; oral

2.0

16.2

178

922

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

3.2

16.1

210

GDC00

NOMESCO Finland

Lobectomy of lung

7.1

16.1

T78.4

ICD-10 Finland

Allergy, unspecified

2.8

16.0

292

UDC00

NOMESCO Finland

Ear microscopy

2.1

16.0

152

746

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.1

16.0

152

746

Z50.1

ICD-10 Finland

Other physical therapy

2.3

16.0

121

541

M02AA07

ATC

piroxicam; topical

1.5

15.9

678

5094

H25.1

ICD-10 Finland

Senile nuclear cataract

1.5

15.9

644

4786

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.0

15.8

184

972

RF210, ,

NOMESCO Finland

3.2

15.8

202

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

15.7

545

3911

N06AA09

ATC

amitriptyline; systemic

1.9

15.7

200

1090

RS221, ,

NOMESCO Finland

4.6

15.7

N06AX21

ATC

duloxetine; oral

1.9

15.6

219

1233

4732A

ICD-9 Finland

Chronic sinusitis, Ethmoidal

85.8

15.6

H66.0

ICD-10 Finland

Acute suppurative otitis media

2.4

15.6

111

483

H04.10

ICD-10 Finland

Dry eye syndrome

1.8

15.5

233

1340

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

15.5

145

707

R03

ICPC

Wheezing

5.0

15.5

49101

ICD-8 Finland

Chronic bronchitis, Nonpurulenta (simplex)

14.9

15.4

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

15.3

742

5716

M81.4

ICD-10 Finland

Drug-induced osteoporosis

7.0

15.3

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.7

15.2

329

C03DA01

ATC

spironolactone; oral

1.8

15.2

265

1594

JN3AD

NOMESCO Finland

Abdominal CT examination

1.8

15.2

263

1580

A04

ICPC

Weakness/tiredness general

1.7

15.1

321

2040

46699

ICD-8 Finland

Acute bronchitis and bronchiolitis

6.1

15.1

J05AB11

ATC

valaciclovir; oral

1.7

15.1

284

1747

J01MA11

ATC

grepafloxacin; oral

45.4

15.1

RF120, ,

NOMESCO Finland

4.9

15.0

N05BA04

ATC

oxazepam; oral

1.6

15.0

484

3413

J12.9

ICD-10 Finland

Viral pneumonia, unspecified

6.8

14.9

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.2

14.9

127

597

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

14.8

717

5511

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.5

14.8

370

-1, ,

NOMESCO Finland

1.5

14.8

526

3789

J20.8

ICD-10 Finland

Acute bronchitis due to other specified organisms

18.5

14.7

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.8

14.6

240

1417

I50.0

ICD-10 Finland

Congestive heart failure

2.0

14.6

168

884

R03DX10

ATC

benralizumab; systemic

+∞

14.6

4939B

ICD-9 Finland

Asthma, unspecified[ASTHMA ALIA DEFINITA CUM EXACERBATIONE]

+∞

14.6

J32.1

ICD-10 Finland

Chronic frontal sinusitis

12.0

14.6

M25.5

ICD-10 Finland

Pain in joint

1.5

14.6

564

4135

WX725

NOMESCO Finland

Noninvasive ventilation

2.3

14.5

118

543

L04AX01

ATC

azathioprine; systemic

2.7

14.5

314

R13

ICD-10 Finland

Dysphagia

2.0

14.5

153

781

B44.9

ICD-10 Finland

Aspergillosis, unspecified

151.2

14.5

J01MA01

ATC

ofloxacin; systemic

2.0

14.5

165

866

A06AD11

ATC

lactulose; oral

1.7

14.4

312

1992

C08DB01

ATC

diltiazem; oral

2.2

14.4

119

552

S51.8

ICD-10 Finland

Open wound of other parts of forearm

5.1

14.3

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.0

14.3

220

R06.5

ICD-10 Finland

Mouth breathing

2.1

14.3

146

736

R01AD

ATC

Corticosteroids

4.8

14.3

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.3

14.2

104

458

ZXD20

NOMESCO Finland

Day surgery

1.8

14.2

234

1384

D11AH05

ATC

dupilumab; topical

42.8

14.1

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

4.3

14.1

M01AH02

ATC

rofecoxib; oral

1.7

14.1

256

1558

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

14.0

166

882

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

3.4

13.9

146

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

4.3

13.9

395

Kela drug reimbursment

Dupilumab

53.8

13.8

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

13.8

334

2193

4221

FHL

Polyp removal from the nasal cavity, sinus puncture or irrigation, or biopsy under general anesthesia or operating room

20.2

13.8

S22.3

ICD-10 Finland

Fracture of rib

2.0

13.7

144

733

M54.4

ICD-10 Finland

Lumbago with sciatica

1.7

13.6

311

2012

D83.0

ICD-10 Finland

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

75.7

13.6

D83.9

ICD-10 Finland

Common variable immunodeficiency, unspecified

75.7

13.6

251, ,

Kela drug reimbursment

+∞

13.6

3027

Kela drug reimbursment

Benralizumab

+∞

13.6

XG460

NOMESCO Finland

Short time oxymetry

3.8

13.6

110

R06AX12

ATC

terfenadine; oral

2.5

13.5

355

318

Kela drug reimbursment

Teriparatide

5.5

13.5

J43.1

ICD-10 Finland

Panlobular emphysema

141.0

13.5

M03BX02

ATC

tizanidine; oral

1.5

13.4

1012

8421

N05BA01

ATC

diazepam; systemic, rectal

1.8

13.4

237

1430

H66.9

ICD-10 Finland

Otitis media, unspecified

2.4

13.4

407

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.9

13.3

186

1044

B37.08

ICD-10 Finland

Other candidal stomatitis

4.7

13.3

UJD02

NOMESCO Finland

Gastroscopy

2.3

13.3

103

465

R51.80

ICD-10 Finland

Headache

1.7

13.2

257

1591

L12

ICPC

Hand/finger symptom/complaint

1.7

13.2

306

1984

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

13.9

13.2

R03BB06

ATC

glycopyrronium bromide; inhalant

13.9

13.2

H05AA02

ATC

teriparatide; parenteral

5.8

13.2

N06AX11

ATC

mirtazapine; oral

1.5

13.2

598

4510

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

2.7

13.1

271

A02BA04

ATC

nizatidine; systemic

2.0

13.1

158

845

T79.3

ICD-10 Finland

Post-traumatic wound infection, not elsewhere classified

3.9

13.1

S16

ICPC

Bruise/contusion

2.6

13.1

283

TKC20

NOMESCO Finland

Catheterisation of bladder

2.0

13.1

138

704

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.7

13.0

255

4912A

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]

16.8

13.0

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

9.4

13.0

R04.0

ICD-10 Finland

Epistaxis

1.9

12.9

162

878

ZYC01

NOMESCO Finland

Remote contact by phone

2.2

12.8

107

498

D86.0

ICD-10 Finland

Sarcoidosis of lung

4.6

12.8

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

4.2

12.8

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

12.8

748

5919

R01

ICPC

Pain respiratory system

3.8

12.7

101

M54.5

ICD-10 Finland

Low back pain

1.5

12.7

616

4700

G44.2

ICD-10 Finland

Tension-type headache

1.7

12.6

226

1367

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

3.7

12.6

111

Z50.5

ICD-10 Finland

Speech therapy

4.5

12.6

D72.1

ICD-10 Finland

Eosinophilia

12.4

12.6

M30.1

ICD-10 Finland

Polyarteritis with lung involvement [Churg-Strauss]

70.4

12.6

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

12.6

520

3842

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.9

12.6

170

944

A99

ICPC

Disease/condition unspecnature/site

1.8

12.6

215

1284

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

12.6

361

2466

GX1R5

NOMESCO Finland

Peak expiratory flow (PEF) measurement

+∞

12.5

49309

ICD-8 Finland

Asthma, Unspecified

+∞

12.5

L14

ICPC

Leg/thigh symptom/complaint

1.9

12.5

174

976

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.9

12.4

210

AA1AD

NOMESCO Finland

CT of head and brain

1.5

12.4

590

4480

R03CC03

ATC

terbutaline; systemic

4.7

12.4

B01AB05

ATC

enoxaparin; parenteral

1.5

12.4

598

4556

P03

ICPC

Feeling depressed

2.0

12.3

135

698

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.6

12.3

321

2143

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.8

12.3

207

1231

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.0

12.2

139

729

M48.0

ICD-10 Finland

Spinal stenosis

1.7

12.2

261

1658

L88

ICPC

Rheumatoid/seropositive arthritis

2.3

12.2

386

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.8

12.1

213

R01AC02

ATC

levocabastine; nasal

3.2

12.1

149

M13.9

ICD-10 Finland

Arthritis, unspecified

2.0

12.0

132

683

R03AL04

ATC

indacaterol and glycopyrronium bromide; inhalant

8.7

12.0

S51.0

ICD-10 Finland

Open wound of elbow

4.2

12.0

C01DA14

ATC

isosorbide mononitrate; oral

1.6

12.0

323

2171

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

2.5

12.0

290

N02AC04

ATC

dextropropoxyphene; oral

2.4

11.9

339

R03DA74

ATC

theophylline, combinations with psycholeptics; systemic

47.0

11.9

D02AX

ATC

Other emollients and protectives

2.9

11.9

199

H01

ICPC

Ear pain/earache

1.8

11.8

191

1121

JN4BD

NOMESCO Finland

Extensive body CT

1.7

11.8

208

1252

D64.9

ICD-10 Finland

Anaemia, unspecified

1.7

11.7

234

1458

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.2

11.7

147

SPAT1342

SPAT

Referral to specialised care

4.1

11.7

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

11.6

315

2118

B05BB01

ATC

electrolytes; parenteral

19.1

11.6

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.5

11.6

438

3171

B01AC04

ATC

clopidogrel; oral

1.6

11.5

331

2257

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.7

11.5

242

1530

Q32.0

ICD-10 Finland

Congenital tracheomalacia

120.8

11.4

P01BA02

ATC

hydroxychloroquine; oral

1.9

11.4

155

862

L02

ICPC

Back symptom/complaint

1.8

11.4

175

1011

S76

ICPC

Skin infection other

2.1

11.4

108

530

ZX108

NOMESCO Finland

Inhalation

5.4

11.4

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

5.4

11.4

XG499

NOMESCO Finland

Other fysiological examination of respiatory function

10.6

11.3

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.9

11.3

149

822

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.0

11.2

119

608

R63.4

ICD-10 Finland

Abnormal weight loss

2.2

11.2

419

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.6

11.2

263

R06.4

ICD-10 Finland

Hyperventilation

4.0

11.2

J01EA01

ATC

trimethoprim; systemic

1.5

11.2

477

3532

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.5

11.2

382

2703

P01

ICPC

Feeling anxious/nervous/tense

1.9

11.2

145

794

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

11.2

314

2128

SPAT1216

SPAT

Assessment of functional ability

1.6

11.2

328

2247

R03DB04

ATC

theophylline and adrenergics; systemic

25.2

11.1

J30.0

ICD-10 Finland

Vasomotor rhinitis

2.8

11.1

195

N30.0

ICD-10 Finland

Acute cystitis

1.6

11.1

328

2250

J04.0

ICD-10 Finland

Acute laryngitis

2.8

11.1

190

R4130

NOMESCO Finland

Speech therapy

2.8

11.0

207

ZXD05

NOMESCO Finland

Urgent procedure

1.5

11.0

491

3666

7862A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Cough

5.8

11.0

DHA10

NOMESCO Finland

Biopsy of cavity of nose

5.1

11.0

L04AA06

ATC

mycophenolic acid; systemic

3.4

11.0

112

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

2.5

11.0

266

R07.3

ICD-10 Finland

Other chest pain

1.7

11.0

202

1231

W22

ICD-10 Finland

Striking against or struck by other object(s)

2.1

11.0

470

G04CA02

ATC

tamsulosin; oral

1.5

11.0

405

2914

A02BX02

ATC

sucralfate; oral

2.3

10.8

367

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.8

10.8

185

1103

UGC02

NOMESCO Finland

Rigid bronchoscopy

12.0

10.8

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

10.8

324

2227

J01CF05

ATC

flucloxacillin; systemic

2.0

10.8

127

673

R43

ICPC

Respiratory, Other diagnostic procedure

5.2

10.8

B01AF02

ATC

apixaban; oral

1.6

10.8

290

1945

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

5.6

10.7

N05BB01

ATC

hydroxyzine; systemic

2.1

10.7

104

515

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.2

10.7

428

J85.1

ICD-10 Finland

Abscess of lung with pneumonia

21.6

10.7

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.7

10.7

185

1108

SPAT1036

SPAT

Maxillary puncture

13.0

10.6

A15.1

ICD-10 Finland

Tuberculosis of lung, confirmed by culture only

60.4

10.6

R49.03

ICD-10 Finland

Atrophic dysphonia

3.5

10.6

100

J02AC02

ATC

itraconazole; systemic

1.6

10.6

300

2036

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

8.0

10.6

R2110

NOMESCO Finland

Giving the first information

2.0

10.6

108

545

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

10.5

421

3075

R5110, ,

SPAT

1.7

10.5

187

1128

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.2

10.5

385

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

3.8

10.5

A08

ICPC

Swelling

1.9

10.5

130

702

H11.3

ICD-10 Finland

Conjunctival haemorrhage

2.1

10.5

445

A01AC01

ATC

triamcinolone; local oral

3.2

10.5

131

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.2

10.4

399

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.5

10.4

255

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.0

10.4

121

640

A92

ICPC

Allergy/allergic reaction NOS

2.9

10.4

169

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

10.3

318

2198

S29

ICPC

Skin symptom/complaint other

1.5

10.3

373

2668

R01BA01

ATC

phenylpropanolamine; oral

2.1

10.3

100

495

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.8

10.2

174

1036

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.1

10.2

101

504

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.3

10.2

326

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

3.2

10.2

123

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

10.1

346

2445

T08

ICPC

Weight loss

3.0

10.1

155

GX1C5, ,

SPAT

7.9

10.1

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

10.1

194

1195

J61

ICD-10 Finland

Pneumoconiosis due to asbestos and other mineral fibres

8.5

10.0

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

10.0

189

1159

-44

ICPC

Preventive immunization/medic

1.8

10.0

161

945

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

2.6

9.9

231

127

Kela drug reimbursment

Transplant complication

3.7

9.9

R49.8

ICD-10 Finland

Other and unspecified voice disturbances

3.7

9.9

S01

ICPC

Pain/tenderness of skin

2.1

9.8

456

N06AB10

ATC

escitalopram; oral

1.5

9.8

290

1984

OAB50, ,

SPAT

1.8

9.8

155

903

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

4.9

9.8

R4120

NOMESCO Finland

Occupational therapy

1.9

9.8

119

639

J05AB01

ATC

aciclovir; systemic

1.5

9.7

380

2757

JN4AD

NOMESCO Finland

Body CT examination

1.6

9.7

229

1486

R05DB05

ATC

pentoxyverine; oral, rectal

2.3

9.7

307

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.7

9.7

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

9.7

454

3410

SPAT1104

SPAT

Monitoring of emergency patient

1.9

9.7

121

655

A41.9

ICD-10 Finland

Sepsis, unspecified

2.3

9.7

333

R01AX03

ATC

ipratropium bromide; nasal

2.8

9.7

170

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

9.6

1158

10163

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

9.6

238

1563

S01GX02

ATC

levocabastine; ophthalmic

2.1

9.6

433

WX730

NOMESCO Finland

Conventional respirator

3.4

9.6

102

WX320

NOMESCO Finland

Spinalanesthesy

1.4

9.6

455

3425

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.3

9.6

328

C01AA05

ATC

digoxin; systemic

1.7

9.6

162

963

R21

ICPC

Throat symptom/complaint

1.6

9.5

274

1863

49104

ICD-8 Finland

Chronic bronchitis, Cum emphysemate

15.1

9.5

WVA20

NOMESCO Finland

Medicine administration

2.5

9.5

236

XW000

NOMESCO Finland

Bone marrow biopsy

2.1

9.5

442

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

9.5

443

3325

SPAT1301

SPAT

No procedures

1.4

9.5

556

4345

B01AA03

ATC

warfarin; systemic

1.5

9.4

367

2659

50300

ICD-8 Finland

Chronic sinusitis, Maxillaris cum empyemate

7.6

9.4

F1246, ,

NOMESCO Finland

30.2

9.4

GDG10

NOMESCO Finland

Bilateral transplantation of lung

30.2

9.4

UKC02

NOMESCO Finland

Cystoscopy

1.5

9.4

297

2064

E000002, ,

ATC

1.7

9.3

159

947

G01AF04

ATC

miconazole; vaginal

2.1

9.3

411

H53.1

ICD-10 Finland

Subjective visual disturbances

1.8

9.3

129

722

WZC00, ,

SPAT

1.6

9.3

250

1673

H65.1

ICD-10 Finland

Other acute nonsuppurative otitis media

4.9

9.3

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.2

9.3

352

H66.4

ICD-10 Finland

Suppurative otitis media, unspecified

4.7

9.3

R35

ICD-10 Finland

Polyuria

1.8

9.2

135

769

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

9.2

269

1836

XF404

NOMESCO Finland

Ambulatory ECG

1.7

9.2

164

990

SPAT1262

SPAT

Handing over of treatment supplies

1.5

9.2

314

2216

GX1D5

NOMESCO Finland

Flow volume spirometry

13.7

9.2

B80

ICPC

Iron deficiency anaemia

2.6

9.1

199

J93.1

ICD-10 Finland

Other spontaneous pneumothorax

5.0

9.1

M01AB55

ATC

diclofenac, combinations; oral

1.8

9.1

133

758

WX872

NOMESCO Finland

Intensive care

2.0

9.1

505

7860A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Dyspnoea and respiratory abnormalities[DYSPNOEA]

4.6

9.1

XQ820

NOMESCO Finland

Exposure to medicinal substance

10.1

9.0

344

Kela drug reimbursment

Omalizumab

36.9

9.0

R27

ICPC

Fear of respiratory disease other

3.7

9.0

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

9.0

482

3703

N03AE01

ATC

clonazepam; systemic

2.0

9.0

514

X57

ICD-10 Finland

Unspecified privation

2.8

9.0

166

A11

ICPC

Chest pain NOS

1.7

9.0

169

1036

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

8.9

1050

9129

XG420

NOMESCO Finland

Time-volume spirometry

18.7

8.9

Z94.2

ICD-10 Finland

Lung transplant status

18.7

8.9

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

3.4

8.9

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

8.9

1179

10439

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.8

8.9

147

869

Z00.0

ICD-10 Finland

General medical examination

1.5

8.9

331

2377

SPAT1336

SPAT

Request for examination

2.2

8.9

320

D86.2

ICD-10 Finland

Sarcoidosis of lung with sarcoidosis of lymph nodes

4.9

8.8

F17.20

ICD-10 Finland

Addiction relationship caused by tobacco addiction relationship currently independent

6.8

8.8

K22.4

ICD-10 Finland

Dyskinesia of oesophagus

4.7

8.8

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.2

8.8

340

R03BA07

ATC

mometasone; inhalant

8.6

8.8

R01AC07

ATC

nedocromil; nasal

10.7

8.8

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

8.8

307

2175

L29

ICPC

Musculoskeletal sympt/complt other

1.7

8.8

167

1026

M05BA06

ATC

ibandronic acid; systemic

2.5

8.8

227

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.9

8.8

103

547

J01CA02

ATC

pivampicillin; oral

2.5

8.8

215

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.4

8.7

246

ZX112

NOMESCO Finland

Subcutaneous

2.6

8.7

186

R60.9

ICD-10 Finland

Oedema, unspecified

1.9

8.7

112

613

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.7

8.7

163

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.1

8.7

362

ZXC60

NOMESCO Finland

Application of heat

3.6

8.7

J41.8

ICD-10 Finland

Mixed simple and mucopurulent chronic bronchitis

50.2

8.7

R03DX05

ATC

omalizumab; parenteral

50.2

8.7

J01.4

ICD-10 Finland

Acute pansinusitis

6.6

8.7

TPH04, ,

SPAT

3.5

8.7

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.9

8.7

107

578

A29

ICPC

General symptom/complaint other

1.5

8.7

254

1734

ZX114

NOMESCO Finland

Intramuscular

3.4

8.6

RD210, ,

NOMESCO Finland

3.3

8.6

R39.1

ICD-10 Finland

Other difficulties with micturition

2.3

8.6

266

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.2

8.6

350

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.7

8.6

164

R07

ICPC

Sneezing/nasal congestion

2.0

8.6

459

SPAT1060

SPAT

Administration of oxygen

8.3

8.6

S21

ICPC

Skin texture symptom/complaint

1.5

8.6

275

1914

N05CD07

ATC

temazepam; oral

1.6

8.6

217

1433

S92.3

ICD-10 Finland

Fracture of metatarsal bone

2.3

8.5

261

SPAT1310

SPAT

Counselling related to known health issue

1.4

8.5

534

4205

M70.6

ICD-10 Finland

Trochanteric bursitis

1.5

8.5

255

1750

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.2

8.5

346

E000003, ,

ATC

2.2

8.5

333

N17

ICPC

Vertigo/dizziness

1.5

8.4

257

1768

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

8.4

326

2355

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.8

8.4

120

678

K02.1

ICD-10 Finland

Caries of dentine

1.3

8.4

897

7656

L16

ICPC

Ankle symptom/complaint

1.6

8.4

200

1300

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.6

8.4

215

1422

RS220, ,

NOMESCO Finland

3.6

8.4

315

Kela drug reimbursment

Clopidogrel

3.6

8.4

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.2

8.4

295

50503

ICD-8 Finland

Nasal polyp, Ethmoidalis

12.8

8.4

M05BA01

ATC

etidronic acid; systemic

4.9

8.4

S81

ICD-10 Finland

Open wound of lower leg

7.9

8.4

A03CA02

ATC

clidinium and psycholeptics; oral

1.9

8.4

111

614

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.0

8.3

457

M79.1

ICD-10 Finland

Myalgia

1.5

8.3

244

1664

D80.6

ICD-10 Finland

Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia

+∞

8.3

J17.2*B44.1

ICD-10 Finland

Pneumonia in other aspergillosis

+∞

8.3

49308

ICD-8 Finland

Asthma, Alia definita

+∞

8.3

M36.8*D80.1

ICD-10 Finland

Systemic disorders of connective tissue in hypogammaglobulinaemia

+∞

8.3

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

8.3

871

7417

J18.0

ICD-10 Finland

Bronchopneumonia, unspecified

3.5

8.3

R52.9

ICD-10 Finland

Pain, unspecified

1.6

8.3

178

1130

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.8

8.2

129

751

L04AA01

ATC

[U] ciclosporin

3.4

8.2

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.8

8.2

125

721

N02BF02

ATC

pregabalin; oral

1.8

8.2

113

632

DC1AD

NOMESCO Finland

Temporalbone CT

3.7

8.2

M79.7

ICD-10 Finland

Fibromyalgia

2.4

8.2

241

J43.8

ICD-10 Finland

Other emphysema

7.6

8.2

GX1K5

NOMESCO Finland

Diffusion capacity

7.6

8.2

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

8.1

517

4075

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.2

8.1

332

N02BF01

ATC

gabapentin; oral

1.6

8.1

183

1175

S01GX05

ATC

lodoxamide; ophthalmic

3.5

8.1

K07

ICPC

Swollen ankles/oedema

1.9

8.1

107

591

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

8.1

252

1742

A02BA03

ATC

famotidine; systemic

2.1

8.1

353

D07AB08

ATC

desonide; topical

1.6

8.0

169

1066

AN1

Coronary angiography

1.6

8.0

208

1380

WX882

NOMESCO Finland

High dependency care

2.4

8.0

212

D06BB03

ATC

aciclovir; topical

2.0

8.0

415

J67.0

ICD-10 Finland

Farmer lung

22.1

8.0

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.6

8.0

209

1389

SPAT1252

SPAT

Overall medication plan or its review

1.7

8.0

132

780

L01BA01

ATC

methotrexate; systemic

2.2

8.0

321

M81.0

ICD-10 Finland

Postmenopausal osteoporosis

2.0

8.0

402

S01GX04

ATC

nedocromil; ophthalmic

3.2

8.0

WX302

NOMESCO Finland

Thoracal epidural anesthesy

1.9

7.9

494

A02BC04

ATC

rabeprazole; oral

1.7

7.9

147

898

L01

ICPC

Neck symptom/complaint

1.5

7.9

260

1818

R07.0

ICD-10 Finland

Pain in throat

1.9

7.9

538

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

4.7

7.9

R25

ICPC

Sputum/phlegm abnormal

13.1

7.9

50708

ICD-8 Finland

Hay fever, Alia definita

7.8

7.9

L20.0

ICD-10 Finland

Besnier prurigo

2.0

7.9

411

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

7.8

252

1753

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

7.8

614

4995

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

2.7

7.8

155

N01

ICPC

Headache

1.7

7.8

156

971

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.7

7.8

142

862

D01BA02

ATC

terbinafine; oral

1.4

7.8

421

3228

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

3.0

7.8

111

7863A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Haemoptysis

9.4

7.8

L05

ICPC

Flank/axilla symptom/complaint

1.8

7.8

123

718

L13

ICPC

Hip symptom/complaint

1.4

7.8

371

2785

A34

ICPC

General and Unspecified, Blood test

3.1

7.7

106

A07DA03

ATC

loperamide; oral

2.2

7.7

292

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

7.7

382

2884

D07AC01

ATC

betamethasone; topical

1.3

7.7

599

4863

Z88.6

ICD-10 Finland

Personal history of allergy to analgesic agent

45.2

7.7

J01DA39

ATC

[U] ceftibuten

15.1

7.7

H26.3

ICD-10 Finland

Drug-induced cataract

6.4

7.7

1300

FHL

Esophagogastroduodenoscopy (also includes staining)

3.9

7.7

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.6

7.7

168

1070

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.5

7.7

180

I45.0

ICD-10 Finland

Right fascicular block

4.4

7.7

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.0

7.7

429

J01MA06

ATC

norfloxacin; oral

1.5

7.6

226

1544

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.8

7.6

113

647

78329

ICD-8 Finland

Symptoms referable to respiratory system, Dyspnoea alia sive NUD

8.1

7.6

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

2.4

7.6

224

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

3.6

7.6

N06AX12

ATC

bupropion; oral

2.0

7.6

396

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.8

7.6

112

641

U71

ICPC

Cystitis/urinary infection other

1.7

7.6

133

800

N39.3

ICD-10 Finland

Stress incontinence

1.7

7.6

141

862

SPAT1131

SPAT

Colonoscopy

2.2

7.6

295

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

7.6

179

1163

SPAT1211

SPAT

Application of soft bandage

1.7

7.5

154

964

M05BX03

ATC

strontium ranelate; oral

4.1

7.5

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.6

7.5

194

1285

SPAT1097

SPAT

Recording of ECG

1.5

7.5

268

1905

E000006, ,

ATC

1.8

7.5

114

659

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.1

7.4

337

I45.1

ICD-10 Finland

Other and unspecified right bundle-branch block

4.4

7.4

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.2

7.4

284

H57.1

ICD-10 Finland

Ocular pain

2.2

7.4

284

E84.0

ICD-10 Finland

Cystic fibrosis with pulmonary manifestations

80.4

7.4

M84.3

ICD-10 Finland

Stress fracture, not elsewhere classified

3.5

7.4

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

7.4

480

3788

R1250

NOMESCO Finland

Evaluation of functional capability

2.4

7.4

196

W19

ICD-10 Finland

Unspecified fall

1.6

7.4

173

1122

WX213

NOMESCO Finland

Lower leg blockade

4.0

7.3

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.3

7.3

253

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.2

7.3

266

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

7.3

233

1618

0310A

ICD-9 Finland

Diseases due to other mycobacteria, Pulmonary

+∞

7.3

R84.5

ICD-10 Finland

Abnormal findings in specimens from respiratory organs and thorax, abnormal microbiological findings

+∞

7.3

R03DX11

ATC

tezepelumab; systemic

+∞

7.3

RF220, ,

NOMESCO Finland

3.1

7.3

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.6

7.3

161

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

2.3

7.3

241

C10AC01

ATC

colestyramine; oral

2.3

7.3

222

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

4.2

7.3

R05DB20

ATC

other cough suppressants - combinations

1.9

7.3

480

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

3.5

7.3

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

7.3

414

3198

R053, ,

ICD-10 Finland

2.2

7.3

254

SPAT1229

SPAT

Assessment of need for aid

1.6

7.3

150

942

H90.6

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, bilateral

2.5

7.2

168

F34.1

ICD-10 Finland

Dysthymia

2.3

7.2

236

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.9

7.2

425

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.8

7.2

122

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.1

7.2

342

XG467

NOMESCO Finland

Nocturnal CO2 monitoring

30.1

7.1

50304

ICD-8 Finland

Chronic sinusitis, Ethmoidalis

20.1

7.1

DPW99

NOMESCO Finland

Other operation on frontal or sphenoidal sinus

20.1

7.1

J98.2

ICD-10 Finland

Interstitial emphysema

20.1

7.1

L50.0

ICD-10 Finland

Allergic urticaria

2.5

7.1

175

DM1BD

NOMESCO Finland

Extensive CT of paranasal sinuses and face area

8.0

7.1

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

7.1

592

4845

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.8

7.1

114

669

SFA20

NOMESCO Finland

Two-surface restoration

1.3

7.1

894

7743

L08

ICPC

Shoulder symptom/complaint

1.4

7.1

386

2960

K03.66

ICD-10 Finland

Tooth plaque

1.7

7.1

131

800

UJF92

NOMESCO Finland

Capsular endoscopy

2.6

7.1

146

Z51.6

ICD-10 Finland

Desensitization to allergens

8.8

7.0

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.0

7.0

393

TNX99

NOMESCO Finland

Other orthopaedic minor procedure

2.3

7.0

213

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.9

7.0

107

L04AD02

ATC

tacrolimus; systemic

3.9

7.0

U02

ICPC

Urinary frequency/urgency

1.4

7.0

277

2008

N06AX16

ATC

venlafaxine; oral

1.5

7.0

202

1374

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.5

6.9

159

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

6.9

612

5045

R44

ICPC

Respiratory, Preventive immunization/medic

2.7

6.9

130

R55

ICD-10 Finland

Syncope and collapse

1.5

6.9

206

1410

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.2

6.9

273

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.9

6.9

467

K22.2

ICD-10 Finland

Oesophageal obstruction

3.6

6.9

ZY000

NOMESCO Finland

Hospital inpatient

3.6

6.9

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

2.3

6.9

209

D11

ICPC

Diarrhoea

1.6

6.8

178

1182

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.7

6.8

131

808

J01X

ATC

OTHER ANTIBACTERIALS

6.7

6.8

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

6.8

706

5947

SBA00

NOMESCO Finland

Microbiological examinations

2.3

6.8

229

J32.3

ICD-10 Finland

Chronic sphenoidal sinusitis

9.3

6.8

A97

ICPC

No disease

1.4

6.8

343

2596

KMAK, ,

NOMESCO Finland

1.3

6.8

755

6422

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

6.8

119

717

A16.0

ICD-10 Finland

Tuberculosis of lung, bacteriologically and histologically negative

16.8

6.7

K59.0

ICD-10 Finland

Constipation

1.8

6.7

105

611

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

6.7

194

1319

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

6.7

669

5606

D84.9

ICD-10 Finland

Immunodeficiency, unspecified

22.6

6.7

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.6

6.7

146

931

H65.0

ICD-10 Finland

Acute serous otitis media

3.0

6.7

D01

ICPC

Abdominal pain/cramps general

1.5

6.7

193

1313

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

6.6

301

2234

A02

ICPC

Chills

3.7

6.6

J11.0

ICD-10 Finland

Influenza with pneumonia, virus not identified

6.4

6.6

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

6.6

381

2944

J93.8

ICD-10 Finland

Other pneumothorax

5.9

6.6

J32

ICD-10 Finland

Chronic sinusitis

5.5

6.6

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.8

6.6

540

JCA55

NOMESCO Finland

Endoscopic dilatation of oesophagus

3.6

6.6

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

12.3

6.6

M81.5

ICD-10 Finland

Idiopathic osteoporosis

3.2

6.6

WVA20, ,

SPAT

2.0

6.6

347

L04AX03

ATC

methotrexate; systemic

1.6

6.6

155

1007

SCA02

NOMESCO Finland

Preventive oral health care

1.6

6.5

139

881

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

6.5

234

1665

R79.8

ICD-10 Finland

Other specified abnormal findings of blood chemistry

3.9

6.4

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

3.2

6.4

4738X

ICD-9 Finland

Chronic sinusitis, Other chronic sinusitis

70.1

6.4

D84.18

ICD-10 Finland

Other specified defect in the complement system

70.1

6.4

C05AA08

ATC

fluocortolone; rectal, topical

1.5

6.4

222

1566

J43.2

ICD-10 Finland

Centrilobular emphysema

7.4

6.4

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.4

6.4

178

K12.00

ICD-10 Finland

Recurrent oral aphthae

3.0

6.4

A03DA02

ATC

pitofenone and analgesics; systemic

2.4

6.4

172

S51.9

ICD-10 Finland

Open wound of forearm, part unspecified

3.8

6.4

B07.9

ICD-10 Finland

Verruca simplex

2.2

6.4

249

H66

ICD-10 Finland

Suppurative and unspecified otitis media

2.7

6.3

125

JAB30

NOMESCO Finland

Repair of inguinal hernia using prosthetic material

1.6

6.3

158

1040

F01

ICPC

Eye pain

2.2

6.3

217

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

1.9

6.3

387

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

6.3

305

2288

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

6.3

127

793

K05.18

ICD-10 Finland

Chronic gingivitis

1.7

6.3

111

669

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

6.3

563

GX2D5

NOMESCO Finland

Sleep oximetry

5.5

6.3

GD5CD

NOMESCO Finland

Thorax and upper abdomen combined very extensive CT examination of

5.5

6.3

1DC02, ,

NOMESCO Finland

11.1

6.3

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

3.5

6.3

207

Kela drug reimbursment

Chronic arrhythmias

1.4

6.3

311

2343

F2682, ,

NOMESCO Finland

18.1

6.3

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

18.1

6.3

E66.8

ICD-10 Finland

Other obesity

2.0

6.3

332

Z2445

NOMESCO Finland

Psychologist

2.2

6.3

218

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.1

6.3

264

N02AA01

ATC

morphine; systemic, rectal

2.4

6.3

180

J06BA02

ATC

immunoglobulins, normal human, for intravascular adm.; systemic

+∞

6.3

D84.19

ICD-10 Finland

Unspecified defect in the complement system

+∞

6.3

GX1C5

NOMESCO Finland

PEF monitoring for assessment of efficacy of asthma management

+∞

6.3

RF531, ,

NOMESCO Finland

+∞

6.3

E66.01

ICD-10 Finland

Obesity due to excess calories

1.7

6.2

115

702

D84.1

ICD-10 Finland

Defects in the complement system

26.8

6.2

J02AC05

ATC

isavuconazole; systemic

26.8

6.2

J20.1

ICD-10 Finland

Acute bronchitis due to Haemophilus influenzae

26.8

6.2

A31.89

ICD-10 Finland

Other mycobacterial infections

26.8

6.2

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.2

6.2

212

E66.9

ICD-10 Finland

Obesity, unspecified

2.2

6.2

212

M54.3

ICD-10 Finland

Sciatica

1.8

6.2

565

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.8

6.2

454

J01AA07

ATC

tetracycline; systemic

1.5

6.2

201

1399

B37.00

ICD-10 Finland

Acute pseudomembraneuous candidal stomatitis

7.0

6.2

C09CA01

ATC

losartan; oral

1.3

6.2

464

3727

XA800

NOMESCO Finland

Neuropsychological investigation

2.1

6.2

292

N03AX09

ATC

lamotrigine; oral

2.1

6.2

265

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

6.2

626

5240

U07

ICPC

Urine symptom/complaint other

1.6

6.2

162

1078

50709

ICD-8 Finland

Hay fever, Unspecified

5.0

6.2

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.9

6.2

369

Z31.5

ICD-10 Finland

Genetic counselling

1.9

6.1

377

A07AA09

ATC

vancomycin; oral

2.8

6.1

110

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

2.0

6.1

314

AA40B, ,

NOMESCO Finland

7.7

6.1

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

2.9

6.1

M02AA10

ATC

ketoprofen; topical

1.4

6.1

264

1943

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.4

6.1

269

1987

5AH02, ,

NOMESCO Finland

12.6

6.1

I20.00

ICD-10 Finland

Unstable angina

2.1

6.1

274

G25.0

ICD-10 Finland

Essential tremor

2.2

6.1

234

S01GX08

ATC

ketotifen; ophthalmic

2.0

6.1

322

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

1.9

6.1

350

XJH00

NOMESCO Finland

Transanal ultrasonography

1.7

6.1

577

NH1AD

NOMESCO Finland

Ankle and foot CT

2.4

6.1

164

S01KA02

ATC

hypromellose; ophthalmic

2.4

6.0

158

K20

ICD-10 Finland

Oesophagitis

2.6

6.0

134

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.6

6.0

133

850

N04BC05

ATC

pramipexole; oral

1.6

6.0

137

882

R05DA01

ATC

ethylmorphine; oral

1.6

6.0

126

795

TQW40

NOMESCO Finland

Remowal of suture of skin

1.7

6.0

116

717

H66.3

ICD-10 Finland

Other chronic suppurative otitis media

5.2

6.0

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

2.9

6.0

OAB50

NOMESCO Finland

Delivery of care equipment and instruction on their use

3.3

6.0

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.1

6.0

282

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

605

587

14.90

307.65

5.2

2.6

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

397

154

32.64

307.65

7.0

3.7

—

(3005322) IgE [Units/volume] in Serum or Plasma

744

677

17.83

307.65

2.5

1.1

299.47

191.65

u/ml

1.63

722

610

(3023419) Bacteria identified in Sputum by Culture

715

185

62.77

307.65

5.6

2.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

390

133.66

307.65

2.2

1.2

2.92

1.29

u/ml

0.89

310

(3028192) IgG subclass 2 [Mass/volume] in Serum

234

123

21.67

304.52

1.5

1.3

2.81

2.82

g/l

0.02

181

(3027135) IgG subclass 1 [Mass/volume] in Serum

234

123

21.67

304.52

1.5

1.3

6.71

7.09

g/l

0.36

183

(3024139) IgG subclass 3 [Mass/volume] in Serum

234

123

21.67

304.52

1.5

1.3

0.38

0.46

g/l

0.84

183

(4062490) Immunoglobulin typing, IgG

234

124

21.49

303.42

1.6

1.3

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

548

1051

7.01

290.30

2.2

1.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

183

28.53

267.86

7.5

3.5

—

(3005719) IgG [Mass/volume] in Serum or Plasma

569

1270

6.05

254.86

4.2

2.8

10.22

10.84

g/l

2.34

549

1158

(3024980) IgG subclass 4 [Mass/volume] in Serum

252

224

12.89

246.75

1.6

1.5

0.77

0.80

g/l

0.10

197

175

(3042631) Mycobacterium sp identified in Specimen

244

216

12.88

239.38

6.9

2.4

—

(3000494) Fungus identified in Specimen by Culture

699

1960

5.15

239.14

3.0

1.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

461

1022

5.69

204.45

2.2

1.8

1.06

1.48

g/l

3.98

438

925

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

274

371

8.51

195.86

2.1

1.5

—

(3006315) Basophils [#/volume] in Blood

1491

8292

5.30

190.29

11.7

6.1

0.05

0.04

e9/l

7.88

1383

7016

(3001604) Monocytes [#/volume] in Blood

1489

8276

5.28

190.08

11.7

6.1

0.67

0.59

e9/l

20.40

1380

6996

(3013115) Eosinophils [#/volume] in Blood

1508

8519

5.37

186.90

12.4

6.4

0.22

0.19

e9/l

11.91

1408

7319

(3019198) Lymphocytes [#/volume] in Blood

1491

8424

5.15

182.72

11.8

6.2

1.89

e9/l

0.04

1399

7314

(3000492) Spirometry study

464

1134

5.14

182.42

2.4

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

250

343

8.28

176.20

1.8

1.4

—

(3018010) Neutrophils/Leukocytes in Blood

1384

7634

4.33

169.17

11.9

6.3

60.11

57.73

11.40

1363

7239

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

805

3121

3.82

168.08

3.3

1.9

—

(3019069) Monocytes/Leukocytes in Blood

1382

7682

4.26

165.36

12.4

6.5

8.88

9.07

1.81

1356

7146

(3022096) Basophils/Leukocytes in Blood

1379

7682

4.22

163.77

12.4

6.5

0.68

0.02

1354

7145

(4015189) Microbial culture of sputum

105

33.69

163.64

5.4

1.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

224

294

8.54

163.55

1.8

1.4

—

(3006504) Eosinophils/Leukocytes in Blood

1377

7668

4.21

163.50

12.4

6.4

2.98

2.77

2.21

1352

7131

(3002030) Lymphocytes/Leukocytes in Blood

1387

7808

4.20

160.93

12.4

6.4

24.68

26.98

13.47

1365

7362

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

664

2338

3.89

158.44

3.0

1.8

—

(42870588) Differential panel, method unspecified - Blood

1141

5717

3.64

156.83

11.1

6.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

188

209

9.91

156.30

1.2

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

102

31.71

156.07

1.8

1.5

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

622

2178

3.81

148.28

3.1

1.8

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1523

9414

4.67

148.20

14.0

9.8

4.85

4.09

e9/l

24.17

1421

8109

(3023368) Bacteria identified in Blood by Culture

1021

5098

3.27

134.41

6.9

4.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

200

295

7.49

131.38

1.7

1.4

—

(3042936) Bacteria identified in Isolate by Culture

633

2448

3.42

126.52

2.7

2.0

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

116

14.17

124.61

1.6

2.2

615.93

466.99

e6/l

1.61

(3011412) CD3 cells [#/volume] in Blood

137

134

10.97

124.45

1.7

2.1

1377.19

1082.78

e6/l

2.53

107

116

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

177

242

7.99

124.16

1.7

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

236

439

6.02

123.60

2.2

1.5

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

201

322

6.89

122.14

1.8

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

201

322

6.89

122.14

1.8

1.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

229

425

6.02

120.13

2.1

1.5

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

114

13.15

117.21

1.9

2.2

273.65

193.47

e6/l

2.92

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

128

137

9.97

108.89

1.9

1.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

507

1886

3.33

105.48

2.7

1.7

—

(3007164) IgA [Mass/volume] in Serum or Plasma

683

3083

2.94

100.71

2.0

1.5

2.60

2.57

g/l

0.10

497

1772

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

104

105

10.44

92.12

1.7

1.9

14.21

15.44

0.43

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

165

291

6.13

90.66

2.3

1.6

—

(1175426) CD3 cells/Lymphocytes in Blood

105

110

10.07

90.56

1.7

1.9

73.08

71.55

0.29

101

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

102

103

10.43

90.32

1.6

2.0

—

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

16.14

88.41

1.3

2.2

29.60

26.88

0.57

(3006245) CD3-CD19+ cells/cells in Blood

15.60

85.71

1.3

2.2

11.11

12.64

0.20

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

234

608

4.27

81.61

1.5

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

169

340

5.37

80.50

1.4

1.1

—

(3027801) Oxygen [Partial pressure] in Arterial blood

492

2095

2.84

77.93

8.0

7.3

10.62

12.43

kpa

15.62

467

2015

(3037692) Legionella sp identified in Specimen by Organism specific culture

14.10

77.86

1.6

1.5

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

492

2096

2.84

77.85

8.0

7.3

5.25

5.05

kpa

3.02

469

2013

(3019977) pH of Arterial blood

490

2094

2.83

76.98

8.0

7.3

7.43

7.42

2.21

282

1137

(3003396) Base excess in Arterial blood by calculation

478

2081

2.76

71.88

8.2

7.2

1.93

0.82

mmol/l

7.35

410

1693

(3021589) Normoblasts [#/volume] in Blood

1109

7182

2.38

69.14

18.3

12.0

0.00

e9/l

2.07

947

5848

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

123

212

6.15

68.92

1.1

1.45

1.56

g/l

1.73

117

194

(3000060) B lymphocytes [#/volume] in Blood

16.16

67.69

1.3

1.9

0.17

0.30

e9/l

0.53

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

1585

12205

3.22

67.49

9.0

4.5

17.99

13.67

mm/h

18.17

1541

11305

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

118

203

6.14

66.22

2.1

1.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

439

1909

2.71

65.49

1.5

1.6

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

182

468

4.21

63.92

2.0

1.3

14.30

15.37

iu/ml

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

322

1202

3.04

63.76

2.7

1.6

—

(21494815) CD4 cells/Lymphocytes in Specimen

122

7.71

63.10

1.8

1.9

42.70

38.88

1.00

122

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

148

6.94

62.37

1.2

1.1

0.91

0.95

u/ml

0.03

(3010726) Horse dander IgE Ab [Units/volume] in Serum

104

8.21

60.80

1.2

1.0

0.71

0.87

u/ml

0.12

(3019060) Gas panel - Arterial blood

288

1037

3.11

60.55

4.9

5.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

116

7.73

60.54

1.1

1.0

1.72

5.13

u/ml

1.13

(44790048) Parainfluenza type 2 nucleic acid detection

114

209

5.75

59.84

2.0

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

114

209

5.75

59.84

2.0

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

114

209

5.75

59.84

2.0

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

114

209

5.75

59.84

2.0

1.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

643

3461

2.32

59.67

2.1

1.8

1.29

1.39

mg/l

0.29

521

2732

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1286

9185

2.34

59.47

8.4

6.8

10.11

11.98

umol/l

10.44

1257

8748

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

940

5923

2.21

59.15

4.2

3.3

1367.96

1533.82

ng/l

0.63

846

5157

(40760892) CBC W Ordered Manual Differential panel - Blood

617

3285

2.32

58.54

7.5

4.9

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

113

211

5.64

58.15

2.1

1.5

—

(3016502) Oxygen saturation in Arterial blood

417

1869

2.59

57.77

8.5

7.6

94.68

95.52

1.99

402

1807

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

73.47

56.46

1.6

1.0

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

288

1083

2.97

55.85

8.9

8.7

25.35

24.12

mmol/l

8.44

277

1063

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1164

8095

2.20

55.68

3.8

2.5

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1284

9288

2.28

55.68

9.4

7.2

1.21

1.22

mmol/l

0.67

1138

7961

(3008401) Mugwort IgE Ab [Units/volume] in Serum

115

7.32

54.48

1.1

0.63

1.72

u/ml

0.48

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

9.22

53.93

3.5

2.4

600.00

1566.09

u/ml

1.90

(3037522) Nuclear Ab [Titer] in Serum

446

2150

2.42

52.28

1.4

1.3

457.01

576.44

titre

0.73

523

(3002179) Metamyelocytes/Leukocytes in Blood

340

1452

2.65

51.47

6.1

4.2

0.60

0.66

0.23

109

477

(3025159) Blasts/Leukocytes in Blood

341

1460

2.64

51.35

6.7

4.6

0.04

0.10

1.18

412

(3017181) Myelocytes/Leukocytes in Blood

350

1520

2.61

51.19

6.3

4.4

0.69

0.90

0.86

110

501

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

326

1367

2.68

51.17

2.0

1.6

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

8.34

50.60

1.1

1.0

2.10

1.92

u/ml

0.05

(3014133) Dog dander IgE Ab [Units/volume] in Serum

7.87

50.33

1.2

1.0

3.15

1.24

u/ml

0.51

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1170

8354

2.11

49.54

9.4

6.5

1.21

mmol/l

1.20

1108

7669

(3021440) Promyelocytes/Leukocytes in Blood

336

1452

2.61

49.51

6.3

4.5

0.03

0.11

2.77

432

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

8.39

49.34

1.1

1.0

0.15

0.56

u/ml

0.58

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

145

6.17

49.14

2.1

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

145

6.17

49.14

2.1

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

145

6.17

49.14

2.1

1.5

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1585

12934

2.68

46.65

12.8

8.5

79.95

81.10

u/l

0.45

1550

12210

(3018418) pH of Serum or Plasma

861

5617

2.01

45.36

5.0

4.3

7.40

0.53

659

4106

(3022948) Iron [Moles/volume] in Serum or Plasma

552

3084

2.13

44.30

2.7

10.75

12.39

umol/l

6.68

521

2864

(3036481) Cortisol [Moles/volume] in Serum or Plasma

340

1556

2.46

43.98

2.8

2.2

295.25

396.17

nmol/l

16.23

323

1429

(3024561) Albumin [Mass/volume] in Serum or Plasma

1123

8115

1.99

43.23

5.6

5.1

33.79

35.14

g/l

11.92

1067

7590

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

764

4843

1.99

43.06

2.9

2.3

2.96

2.88

mg/l

0.42

692

4133

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

165

5.42

42.89

2.4

1.7

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

175

5.23

42.17

2.4

1.7

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

518

2888

2.11

41.35

2.6

2.28

2.26

g/l

0.29

487

2654

(3017732) Neutrophils [#/volume] in Blood

406

2080

2.22

40.08

3.4

3.2

5.37

4.79

e9/l

0.47

371

1750

(40758558) Short blood count panel - Blood

777

5053

1.93

39.77

9.1

6.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

122

331

3.88

39.50

1.4

1.3

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

484

2678

2.10

39.11

2.7

18.67

21.99

7.39

458

2482

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

138

423

3.45

37.26

2.4

2.0

11.28

13.04

mg/l

1.26

128

384

(3000991) Gas panel - Venous blood

327

1576

2.31

37.14

9.0

7.9

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

102

6.26

36.27

1.9

1.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

69.74

36.08

1.5

2.2

46.51

40.83

umol/l

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

581

3529

1.95

35.57

5.9

4.0

187.16

354.89

ng/l

2.33

482

2938

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

320

1556

2.28

35.47

3.7

3.1

208.54

209.61

ng/l

0.01

291

1427

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1019

7407

1.85

35.38

3.8

3.0

134.72

137.43

ug/l

0.04

963

6791

(3002173) Hemoglobin [Mass/volume] in Arterial blood

349

1762

2.21

35.29

9.0

7.8

122.05

118.81

g/l

2.27

340

1722

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

262

1174

2.44

34.98

6.7

3.9

5.17

5.14

kpa

0.25

256

1124

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

177

661

2.86

34.12

2.1

1.9

35.83

40.00

u/l

2.24

153

571

(3014111) Lactate [Moles/volume] in Serum or Plasma

331

1665

2.21

33.65

8.3

6.7

1.29

1.37

mmol/l

0.81

320

1636

(3012544) pH of Venous blood

363

1901

2.13

33.28

4.1

3.6

7.38

0.51

206

1113

(3031040) Bacteria [#/volume] in Urine by Automated count

1387

11228

1.97

33.21

7.1

5.3

64.11

1718.06

e6/l

3.19

172

(3021447) Carbon dioxide [Partial pressure] in Venous blood

360

1881

2.14

33.20

4.0

3.5

6.04

5.79

kpa

3.10

348

1834

(3009343) pH of Capillary blood

253

1143

2.41

33.08

6.7

3.9

7.42

2.64

215

937

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

6.52

32.97

2.4

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

6.52

32.97

2.4

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

6.52

32.97

2.4

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

6.52

32.97

2.4

1.6

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

512

3047

1.94

32.86

5.0

3.2

0.81

0.82

mmol/l

0.16

475

2861

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

6.34

32.69

2.1

1.4

—

(3030467) Casts [#/volume] in Urine by Automated count

745

5006

1.82

32.61

4.8

3.4

0.38

0.48

e6/l

0.69

566

3723

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

112

327

3.58

32.54

1.2

1.1

3.40

3.43

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

486

2869

1.94

31.79

1.4

1.3

38.86

34.32

iu/ml

0.21

169

906

(3032080) INR in Blood by Coagulation assay

1112

8456

1.80

31.73

17.1

17.3

1.27

1.31

inr

1.44

946

7057

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

120

5.40

31.65

1.4

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

141

484

3.07

31.56

4.0

3.7

2.25

2.06

index

0.10

249

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

106

305

3.63

31.47

1.6

1.2

551.43

335.38

titre

0.37

(3002032) Base excess in Venous blood by calculation

349

1837

2.11

31.42

4.0

3.6

2.77

1.79

mmol/l

4.47

316

1581

(3033658) Prothrombin time (PT) actual/Normal

666

4365

1.83

31.33

5.8

4.1

89.24

87.16

1.35

651

4266

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

6.15

31.18

2.1

1.4

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

232

1035

2.42

31.11

10.7

9.8

16.08

15.68

1.43

224

998

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

276

3.73

30.79

2.3

1.4

13.60

10.52

u/ml

—

(3002582) Erythrocytes [#/volume] in Urine

826

5799

1.77

30.62

4.8

3.5

72.69

95.98

e6/l

0.39

642

4472

(3013826) Glucose [Moles/volume] in Serum or Plasma

1276

10178

1.84

30.34

7.6

4.9

6.50

6.78

mmol/l

6.90

1238

9702

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

130

5.07

29.93

2.0

1.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

457

2705

1.92

29.33

1.3

19.37

14.10

u/ml

0.56

158

955

(3018095) Leukocytes [#/volume] in Urine

897

6525

1.73

28.72

5.8

4.1

51.17

118.84

e6/l

3.88

658

4639

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

167

4.45

28.72

1.1

3.15

4.56

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

923

6798

1.72

28.00

5.7

4.1

35.20

125.29

ng/l

0.84

721

5185

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

6.75

27.27

2.6

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

6.75

27.27

2.6

1.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

205

916

2.39

27.26

1.9

1.5

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

6.65

26.88

2.6

1.7

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

217

1003

2.32

26.70

6.8

3.7

2.16

1.92

mmol/l

0.47

174

737

(3047007) Chlamydophila sp Ab [Presence] in Serum

161

4.35

26.43

1.3

1.2

—

(3022313) Gas panel - Capillary blood

187

815

2.44

26.25

7.7

3.9

—

(40768797) Stomach Pathology biopsy report

402

2367

1.89

25.81

1.3

1.2

—

(3026782) Osmolality of Urine

540

3514

1.76

24.84

3.8

3.0

497.79

523.57

mosm/kgh2o

2.52

475

3084

(3027945) Reticulocytes/Erythrocytes in Blood

389

2300

1.88

24.52

2.8

2.7

1.75

1.79

0.35

339

2039

(3014007) Fractional oxyhemoglobin in Arterial blood

240

1199

2.15

24.34

10.6

8.7

92.97

93.89

1.19

240

1192

(3008152) Bicarbonate [Moles/volume] in Arterial blood

227

1111

2.19

24.25

8.1

6.7

25.54

24.28

mmol/l

4.48

218

1060

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

129

492

2.74

23.77

2.1

1.6

—

(3000850) Epithelial cells [#/volume] in Urine

601

4077

1.71

23.57

3.6

2.7

5.03

5.76

e6/l

0.76

552

3706

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1014

7881

1.64

23.31

3.2

2.5

83.24

79.91

nmol/l

3.12

954

6968

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

742

5348

1.65

22.93

3.8

3.2

28.92

34.77

u/l

5.14

704

5020

(3024354) Oxygen [Partial pressure] in Venous blood

286

1565

1.98

22.58

3.8

3.0

4.51

4.45

kpa

0.20

273

1524

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

455

2893

1.76

22.31

4.3

3.2

2.65

2.62

e6/l

0.02

224

1458

(3018677) aPTT in Platelet poor plasma by Coagulation assay

433

2723

1.77

22.02

2.5

2.1

29.82

29.65

0.20

422

2637

(3035933) Granulocytes/Leukocytes in Blood

104

369

2.93

21.91

3.9

3.2

57.81

58.90

0.33

104

369

(3035715) Granulocytes [#/volume] in Blood

295

3.12

21.12

3.4

3.3

4.82

4.21

e9/l

1.35

295

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

478

3139

1.71

20.65

4.1

3.1

0.92

1.22

e6/l

1.59

250

1706

(3026008) Bacteria identified in Urine by Culture

801

5996

1.60

20.53

4.2

3.5

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

312

1819

1.86

20.20

2.8

2.2

0.20

g/l

0.01

296

1689

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

742

5473

1.60

20.12

2.9

2.6

56.15

76.44

u/l

0.74

699

5034

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

368

2263

1.78

19.99

4.3

4.5

231.58

254.46

u/l

2.46

352

2131

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

5.81

19.80

1.8

2.5

3870.92

43342.91

u/ml

0.46

(3021960) Folate [Moles/volume] in Serum or Plasma

748

5577

1.58

19.08

2.0

1.8

19.79

20.63

nmol/l

0.84

670

4623

(3020630) Protein [Mass/volume] in Serum or Plasma

295

1719

1.85

19.05

2.7

2.9

65.21

66.25

g/l

1.48

272

1558

(3021601) Nitrite [Presence] in Urine by Test strip

1078

8745

1.57

18.83

5.1

4.3

0.00

estimate

0.80

244

1860

(3021901) Oxygen saturation in Capillary blood

361

2.78

18.73

3.0

3.1

90.05

89.02

0.77

349

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

118

486

2.53

18.63

1.5

31.33

0.12

iu/ml

0.48

(3009261) Glucose [Presence] in Urine by Test strip

1093

8933

1.55

18.16

5.2

4.3

0.00

0.18

estimate

0.55

233

1797

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

153

720

2.23

17.88

3.5

1.9

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1019

8217

1.54

17.86

2.5

2.3

93.75

95.62

pmol/l

0.64

556

4220

(3035350) Ketones [Presence] in Urine by Test strip

1083

8860

1.54

17.69

5.2

4.3

6.78

4.14

estimate

0.15

247

1922

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

136

612

2.32

17.67

3.4

3.2

0.33

0.37

iu/ml

0.50

355

(3006184) Hemoglobin [Mass/volume] in Capillary blood

105

422

2.58

17.44

2.0

2.3

123.62

126.86

g/l

0.54

335

(3026493) Urate [Moles/volume] in Serum or Plasma

608

4405

1.57

17.11

3.6

2.9

346.97

345.17

umol/l

0.15

532

3806

(3028433) Virus identified in Specimen by Culture

5.96

17.00

1.4

—

(3015736) pH of Urine

888

6998

1.52

16.97

4.5

3.8

6.37

6.28

1.41

442

3821

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

101

4.34

16.93

1.9

2.6

40.05

39.49

0.06

(3026389) Candida sp identified in Specimen by Organism specific culture

204

3.27

16.91

1.6

1.4

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1682

15455

2.09

16.74

41.6

17.5

26.25

25.83

mg/l

0.25

1609

12858

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

338

2.72

16.55

12.3

5.2

213.44

836.06

iu/ml

0.99

(3015171) Extractable nuclear Ab [Units/volume] in Serum

131

598

2.28

16.46

1.2

0.35

0.42

u/ml

0.12

(3023520) Reticulocytes [#/volume] in Blood

296

1805

1.76

16.27

2.8

2.7

68.54

68.08

e9/l

0.08

198

1333

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

278

1668

1.79

16.15

2.4

2.3

33.31

37.71

u/l

0.73

239

1409

(3004119) Hemoglobin [Mass/volume] in Venous blood

210

1156

1.92

16.04

3.3

3.1

126.38

126.72

g/l

0.08

204

1118

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

499

3516

1.58

15.58

1.4

1.3

0.85

1.44

u/ml

2.16

122

882

(3020779) Urea [Moles/volume] in Serum or Plasma

273

1653

1.77

15.33

8.2

7.0

9.84

10.63

mmol/l

1.10

262

1582

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

132

629

2.18

14.94

1.4

1.3

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

733

5652

1.50

14.94

2.7

2.2

208.01

207.33

u/l

0.00

685

5320

(3025018) Bordetella pertussis Ab [Titer] in Serum

4.66

14.72

1.4

1.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

813

6459

1.47

13.96

3.3

3.6

2.35

2.36

mmol/l

1.84

737

5819

(40757373) Influenza virus identified in Isolate

6.54

13.66

1.9

1.7

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

133

663

2.08

13.41

3.1

1.8

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

4.31

13.39

1.1

1.0

10.82

14.66

iu/ml

—

(21494814) CD8 cells/Lymphocytes in Specimen

4.90

13.33

2.6

1.7

31.76

30.28

0.15

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

101

452

2.31

13.31

1.2

1.3

11.00

7.04

u/ml

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

100

450

2.29

13.01

1.2

11.57

3.34

u/ml

—

(3023199) Leukocytes [#/volume] in Pleural fluid

267

2.69

12.95

1.4

2465.57

4805.45

e6/l

0.32

189

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

128

3.50

12.94

1.2

1.1

311.43

143.91

titre

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

155

829

1.95

12.85

5.5

5.3

1.67

1.54

1.44

148

781

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

142

737

2.00

12.83

2.5

3.9

40.75

63.22

mg/l

0.73

117

641

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

148

780

1.98

12.81

2.5

1.9

1.06

2.29

ug/l

1.12

136

680

(3003434) Protein [Mass/volume] in Pleural fluid

298

2.58

12.80

1.5

34.22

31.60

g/l

1.03

269

(3047181) Lactate [Moles/volume] in Blood

109

516

2.18

12.56

7.4

6.6

1.20

1.29

mmol/l

0.58

455

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

299

1952

1.64

12.55

1.5

1.4

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

302

1980

1.63

12.45

2.4

2.7

7.32

8.87

umol/l

0.69

267

1752

(3034860) Kappa light chains.free [Mass/volume] in Serum

141

738

1.99

12.44

2.6

3.9

79.99

62.82

mg/l

0.22

115

640

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

339

2.45

12.41

1.2

12.93

51.49

u/ml

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

173

971

1.86

12.39

3.5

2.7

1.20

1.12

0.48

173

964

(3003458) Phosphate [Moles/volume] in Serum or Plasma

366

2515

1.57

12.39

6.7

5.4

1.05

1.04

mmol/l

0.71

339

2314

(3048689) Calprotectin [Mass/mass] in Stool

291

1900

1.63

12.18

2.1

2.2

306.94

134.98

ug/g

1.34

231

1491

(3028308) Erythrocytes [#/volume] in Pleural fluid

241

2.72

12.16

1.4

1.3

69436.79

103221.94

e6/l

0.27

138

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

170

960

1.85

11.94

3.5

2.6

0.64

0.63

0.11

170

955

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

3.98

11.75

1.0

1.1

—

(3045788) Cell count panel - Pleural fluid

224

2.74

11.60

1.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

126

650

2.01

11.59

9.7

4.0

25.23

24.78

mmol/l

1.00

117

594

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1150

9947

1.42

11.38

4.4

3.4

50.49

52.46

u/l

0.31

1083

9199

(1616796) Gas panel - Central venous blood

385

2.29

11.35

5.4

4.1

—

(3037756) Immunofixation for Serum or Plasma

462

2.16

11.03

1.4

1.7

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

516

3899

1.45

10.87

2.9

3.1

2.49

2.46

mmol/l

4.79

452

3527

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

120

623

1.99

10.85

2.7

0.01

g/l

0.04

113

558

(3023420) DNA double strand Ab [Units/volume] in Serum

125

664

1.95

10.58

1.8

1.7

3.15

7.64

iu/ml

2.75

162

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

125

664

1.95

10.58

2.6

3.7

6.59

4.24

ratio

0.26

401

(3003181) Sodium [Moles/volume] in Urine

387

2.23

10.38

1.5

1.3

59.44

60.77

mmol/l

0.11

310

(3007930) Methemoglobin/Hemoglobin.total in Blood

138

764

1.87

10.32

5.9

5.6

0.89

0.88

0.09

131

721

(3012441) Differential panel - Pleural fluid

222

2.62

10.18

1.5

1.4

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

110

569

1.99

10.06

2.8

0.00

g/l

-0.00

104

531

(3004809) Band form neutrophils/Leukocytes in Blood

315

2.34

10.05

4.4

4.1

1.25

1.62

0.33

286

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

195

2.72

10.00

1.5

1.3

612.26

348.81

u/l

1.07

189

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

136

763

1.85

9.76

2.5

2.8

9.89

10.45

g/l

0.77

124

663

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

441

2.09

9.55

3.1

2.3

190.12

199.37

0.46

421

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

143

823

1.80

9.45

2.6

2.7

3.11

2.95

g/l

1.17

136

732

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

113

604

1.93

9.41

2.7

0.01

0.00

g/l

0.50

104

532

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

152

2.87

9.25

1.3

14.92

11.71

u/l

0.81

141

(3035880) pH of Pleural fluid

120

3.13

9.23

1.2

1.3

7.40

7.41

0.10

(3014051) Protein [Presence] in Urine by Test strip

579

4573

1.39

9.21

3.9

3.3

0.00

0.06

1.49

145

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

198

2.62

9.19

1.4

1.2

1.64

3.50

u/ml

0.76

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

252

2.43

9.19

6.4

2.8

880.00

983.19

u/ml

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

149

879

1.76

9.06

2.6

2.7

7.81

7.41

g/l

2.08

142

787

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

149

879

1.76

9.06

2.6

2.7

4.26

4.18

g/l

0.55

141

788

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

149

879

1.76

9.06

2.6

2.7

3.71

3.67

g/l

0.12

142

787

(3051611) Lipemic interference index of Serum or Plasma

188

2.65

9.05

3.9

3.3

13.94

11.82

index

0.62

103

(3017569) Oxygen content in Arterial blood

3.34

8.91

1.5

2.6

15.75

15.97

0.10

(44813793) Dust mix specific IgE antibody measurement

3.74

8.90

1.0

1.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

132

760

1.79

8.72

2.8

2.7

1.00

1.30

g/l

0.46

122

643

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

235

1575

1.56

8.69

3.2

2.4

6.94

7.22

ug/l

0.09

195

1379

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

100

528

1.95

8.65

1.5

1.3

—

(40768804) Tissue Pathology biopsy report

802

6718

1.34

8.63

2.5

2.2

—

(3036489) Thrombin time

108

586

1.90

8.62

2.7

2.0

22.06

21.25

0.30

534

(3039000) Anion gap in Blood by calculation

357

2.15

8.60

8.2

8.0

11.04

11.22

mmol/l

0.18

319

(3018572) Chloride [Moles/volume] in Blood

357

2.15

8.60

8.2

8.0

103.90

105.37

mmol/l

1.31

319

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

401

2.07

8.39

1.8

1.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

270

1883

1.51

8.31

4.4

3.6

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

8.57

8.30

1.2

1.3

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

8.96

8.04

2.8

1.9

—

(36660697) Celiac disease serology panel - Serum

193

1259

1.60

8.01

1.2

—

(40768806) Pleura Pathology biopsy report

219

2.41

7.96

1.5

1.6

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1353

12367

1.36

7.51

5.1

4.5

15.11

14.98

pmol/l

1.08

1264

11178

(3022145) Colonoscopy Study observation

266

1893

1.47

7.38

1.4

1.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

153

962

1.64

7.37

1.5

1.7

1.82

1.53

g/l

2.97

129

831

(4195642) Thrombophilia screening test

172

2.54

7.36

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

192

2.43

7.21

1.5

1.2

2.71

7.78

u/ml

1.30

(3000570) Elastase.pancreatic [Mass/mass] in Stool

102

577

1.81

7.18

1.3

1.4

288.42

279.31

ug/g

0.17

330

(3019309) Folate [Moles/volume] in Red Blood Cells

434

3388

1.37

7.12

1.9

1.8

1189.56

1159.17

nmol/l

0.24

329

2527

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

157

2.58

7.12

1.3

—

(3020874) Milk IgE Ab [Units/volume] in Serum

4.39

6.96

1.1

1.04

4.11

u/ml

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

226

1577

1.49

6.91

3.7

85.60

91.30

ng/l

0.54

198

1341

(3012501) Base excess in Blood by calculation

356

2.00

6.80

6.7

4.6

2.48

2.68

mmol/l

0.33

239

(3001964) Herpes simplex virus Ag [Presence] in Specimen

4.28

6.75

2.4

1.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

180

2.42

6.72

1.3

1.1

—

(40768443) Skin Pathology biopsy report

126

777

1.67

6.56

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

209

2.28

6.43

1.2

1.3

—

(3008295) Osmolality of Serum or Plasma

203

2.30

6.40

1.4

1.3

272.41

275.03

mosm/kgh2o

0.30

151

(3003327) Ova and parasites identified in Stool by Light microscopy

475

1.83

6.26

1.6

—

(3002523) Influenza virus A Ag [Presence] in Specimen

180

2.36

6.25

1.3

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

3.04

6.08

1.1

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

113

692

1.67

6.06

3.4

2.1

416.69

844.96

ug/l

0.74

106

656

(3019550) Sodium [Moles/volume] in Serum or Plasma

1683

16118

1.55

6.05

41.0

21.5

139.12

139.67

mmol/l

13.99

1667

15808

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

309

2.01

6.03

1.3

—

(4268621) Lupus anticoagulant assay

135

2.55

5.96

2.6

2.2

—

(3029937) Albumin [Presence] in Urine by Test strip

597

4993

1.29

5.87

5.6

4.5

0.00

estimate

1.15

229

1700

(3000012) Reticulocyte production index

285

2.03

5.84

2.6

2.2

0.92

0.88

0.22

199

(40761511) CBC panel - Blood by Automated count

1645

15702

1.47

5.77

28.0

16.0

—

(3010375) cycloSPORINE [Mass/volume] in Blood

3.36

5.72

37.1

24.1

131.69

131.74

ug/l

0.00

(3023103) Potassium [Moles/volume] in Serum or Plasma

1683

16143

1.53

5.72

41.3

21.7

3.97

3.99

mmol/l

2.15

1666

15808

(40759836) Histone Ab [Presence] in Serum by Immunoblot

121

2.59

5.64

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

189

2.25

5.63

4.7

4.9

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

116

2.61

5.56

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

185

2.24

5.46

1.2

1.1

—

(3045424) Erythrocytes [Presence] in Urine

132

868

1.56

5.33

1.9

2.3

0.00

1.04

estimate

0.50

242

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

119

2.55

5.30

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

119

2.55

5.30

1.1

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

1579

15013

1.38

5.19

31.8

17.7

77.07

75.16

ml/min/173m2

3.35

1511

14058

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

127

2.47

5.13

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

4.87

5.12

1.1

1.0

0.42

0.05

u/ml

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

6.35

5.08

1.2

1.0

3.79

6.04

u/ml

—

(3011897) Casein IgE Ab [Units/volume] in Serum

8.37

5.06

1.0

1.7

0.06

0.56

u/ml

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

457

1.74

4.96

4.0

3.4

0.79

nmol/l

0.00

369

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

156

2.27

4.83

1.2

1.1

—

59.88

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

4.24

4.82

1.1

1.0

0.47

1.47

u/ml

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.69

4.75

1.2

—

(3017704) Immunofixation for Urine

126

2.40

4.73

1.1

1.8

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

4.69

4.68

2.0

1.3

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

144

994

1.49

4.67

3.3

3.4

4.20

4.39

pmol/l

1.98

129

872

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

109

2.50

4.63

1.7

1.5

6.41

6.63

u/l

0.02

(3017354) Segmented neutrophils/Leukocytes in Blood

206

2.06

4.60

4.3

4.2

60.47

56.83

0.61

179

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

148

2.25

4.51

1.2

1.1

—

(3018333) Ribosomal P Ab [Presence] in Serum

111

2.45

4.47

1.1

—

(3025941) Bacteria identified in Stool by Culture

119

797

1.53

4.47

1.4

1.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1535

14606

1.32

4.43

6.6

5.7

1.88

2.00

mu/l

2.74

1448

13295

(3041096) Erythrocytes [Presence] in Urine by Automated

534

4540

1.25

4.34

4.7

3.8

1.27

0.23

estimate

0.40

205

1450

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

113

2.41

4.32

1.1

—

(3044640) Blood type and Crossmatch panel - Blood

653

5684

1.23

4.26

3.1

2.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

198

1478

1.38

4.21

1.6

1.5

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

148

1052

1.44

4.16

2.5

10.92

21.60

au/ml

1.93

(1002224) Polysomnography panel

539

1.61

4.07

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

563

1.59

4.06

1.6

36.22

19.18

u/ml

0.77

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

511

4354

1.24

4.03

3.0

2.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

457

3846

1.25

4.03

1.8

16364117.17

20244263.15

pmol/l

0.08

385

3117

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

879

7916

1.21

4.02

3.2

2.8

—

estimate

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

3.14

3.93

1.7

1.5

0.21

0.47

ug/l

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

134

946

1.45

3.91

1.4

1.3

31.22

54.30

au/ml

—

(3050794) Legionella sp Ab [Presence] in Serum

6.02

3.81

1.2

1.0

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

181

1354

1.37

3.81

2.6

2.8

65.30

62.20

ml/min/173m2

0.52

605

(3021879) Hepatitis B virus core Ab [Presence] in Serum

139

994

1.43

3.80

1.5

1.4

—

(3033099) Centromere Ab [Titer] in Serum

3.96

3.79

1.0

1.1

—

(3002619) Bacteria identified in Specimen by Culture

3.84

3.69

1.7

1.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

199

1521

1.35

3.66

4.1

3.7

1.22

1.23

mmol/l

1.68

180

1288

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

2.49

3.63

2.6

1.9

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

730

6508

1.20

3.59

5.5

4.4

0.14

0.45

estimate

0.40

207

1523

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

7.80

3.56

1.7

1.6

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

5.31

3.51

1.2

1.1

1.02

0.15

u/ml

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

5.31

3.51

1.1

1.0

—

(3034426) Prothrombin time (PT)

3.63

3.49

1.2

1.3

27.46

29.14

0.51

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1676

16250

1.37

3.49

19.8

13.1

24.09

24.56

u/l

0.53

1656

15727

(3042733) HLA Ab [Presence] in Serum

3.53

3.40

4.1

3.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

135

983

1.40

3.36

2.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

2.38

3.32

1.2

1.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

2.55

3.29

1.1

1.0

—

(3045414) Leukocytes [Presence] in Urine

222

1751

1.30

3.29

2.1

2.2

0.04

0.02

estimate

0.25

327

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

184

1.92

3.25

2.8

2.9

—

(3005011) Chlamydia sp Ab [Titer] in Serum

5.35

3.19

1.4

1.5

—

(3052592) Norovirus Ag [Presence] in Stool

3.81

3.18

1.5

1.6

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

3.81

3.18

1.8

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

366

1.63

3.15

1.3

1.2

—

(3006576) Bicarbonate [Moles/volume] in Blood

2.97

3.13

4.3

7.1

26.69

24.99

mmol/l

1.00

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

2.48

3.13

1.2

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

2.27

3.03

1.2

152.00

138.45

nmol/l

0.69

(3035637) Corticotropin [Mass/volume] in Plasma

196

1.85

3.03

1.3

1.6

26.57

29.51

ng/l

0.18

196

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

197

1.84

2.99

2.3

1.6

—

(21491868) Cryoglobulin [Mass/volume] in Serum

2.55

2.96

1.2

1.3

—

0.43

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

219

1752

1.28

2.93

1.6

1.5

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1688

16441

1.34

2.89

43.9

23.9

78.16

79.32

umol/l

0.60

1678

16242

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

259

1.72

2.88

1.5

1.2

258.00

271.80

u/ml

0.13

146

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

4.11

2.88

1.4

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

4.11

2.88

1.4

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

4.11

2.88

1.4

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

252

1.72

2.86

2.9

2.4

30.63

24.83

mg/l

0.36

(3014765) Yersinia sp identified in Stool by Organism specific culture

448

1.54

2.85

1.3

1.2

—

(3010838) Calcium [Moles/time] in 24 hour Urine

329

1.63

2.85

2.2

1.9

4.26

4.60

mmol/24h

0.39

281

(3006571) Granulocytes/Leukocytes in Synovial fluid

186

1.84

2.84

1.4

1.5

55.73

62.59

0.45

116

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

441

1.54

2.83

1.3

1.2

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.65

2.79

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.65

2.79

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.65

2.79

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.65

2.79

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

452

1.52

2.75

1.3

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

264

1.68

2.71

1.9

1.3

159.46

153.60

au/ml

0.13

(21494567) Legionella sp IgM Ab [Presence] in Serum

6.02

2.70

1.2

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

6.02

2.70

1.2

1.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

199

1.77

2.61

1.5

1.3

—

nmol/l

—

(3044242) Glucose [Moles/volume] in Arterial blood

107

2.07

2.57

2.0

2.4

7.56

8.96

mmol/l

0.87

107

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

4.01

2.57

2.8

1.7

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.87

2.54

1.7

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

203

1.74

2.45

1.4

1.3

0.20

0.18

nmol/l

0.44

169

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.14

2.43

1.0

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.14

2.43

1.1

1.3

—

(3014271) Vancomycin [Susceptibility]

2.10

2.43

3.6

2.7

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

197

1.74

2.40

1.1

1.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

3.04

2.35

4.7

6.6

5.40

5.23

kpa

—

(3008898) HLA-B27 [Presence]

388

1.51

2.32

1.1

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

238

1.65

2.30

1.4

1.3

0.53

8.13

nmol/l

0.51

228

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

4.63

2.27

1.0

122.67

96.00

titre

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

248

1.63

2.22

2.0

1.4

—

(3009508) Creatinine [Moles/volume] in Urine

673

6150

1.15

2.17

3.5

3.4

6.39

7.02

mmol/l

3.83

568

5108

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

404

1.48

2.14

1.5

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

236

1.62

2.11

2.0

1.4

—

(37208534) Antinuclear antibody arbitrary concentration in serum

2.46

2.10

1.0

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

245

1.60

2.08

2.0

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

238

1.61

2.05

2.0

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

238

1.61

2.05

2.0

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

408

1.46

2.05

1.4

1.3

34.86

32.51

iu/l

0.18

350

(3017446) Testosterone [Moles/volume] in Serum or Plasma

128

1005

1.29

2.04

2.5

2.3

13.86

12.75

nmol/l

0.75

107

891

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

300

0.50

2.02

1.1

1.2

1.60

1.57

g/l

0.13

300

(1617658) Protocol used for examination of sentinel lymph nodes

161

0.37

2.02

1.2

1.0

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

248

2103

1.21

2.00

3.1

4.2

4.29

19.37

ug/l

3.07

217

1720

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.64

2.00

4.7

6.6

5.70

5.97

kpa

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

296

1.53

1.99

1.9

1.3

—

(3023410) Appearance of Cerebral spinal fluid

163

1.73

1.98

1.2

1.6

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

546

1.39

1.98

1.5

1.7

0.27

0.33

mg/l

0.43

236

(3028707) Methadone [Presence] in Urine by Screen method

105

1.91

1.95

2.4

1.6

—

(3002079) Sodium [Moles/time] in 24 hour Urine

2.20

1.94

1.4

1.3

140.07

161.15

mmol/24h

0.42

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.57

1.94

1.0

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

116

906

1.30

1.93

1.4

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.76

1.93

1.0

1.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

447

1.42

1.93

1.7

1.6

6999.80

12733.52

e6/l

1.43

320

(4027681) Cerebrospinal fluid IgG ratio and IgG index

2.12

1.92

1.1

1.2

0.51

0.49

ratio

—

(3036670) Protein [Mass/volume] in Synovial fluid

2.32

1.87

1.3

1.2

38.34

38.02

g/l

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

151

1.73

1.87

1.4

1.2

108.54

107.24

pmol/l

0.04

151

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

245

1.56

1.85

1.5

1.3

—

0.44

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.21

1.84

1.3

318.83

566.36

ug/l

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

294

1.51

1.83

1.8

260.08

300.99

mu/l

0.80

269

(3004716) Salmonella sp identified in Stool by Organism specific culture

642

1.34

1.81

1.4

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

153

1.71

1.80

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

248

1.54

1.76

2.0

1.4

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

139

1.74

1.76

1.5

31.66

29.00

0.15

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

726

6741

1.13

1.75

1.9

2.0

1.30

1.31

mmol/l

0.07

596

5530

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.34

1.74

1.0

1.2

0.02

u/ml

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

155

1.69

1.73

1.3

1.4

21.60

22.76

u/ml

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

2.92

1.72

1.1

20.37

39.61

iu/ml

—

(3044927) Protein electrophoresis panel - Urine

226

1.56

1.71

1.1

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

1.70

0.0

1.1

—

(3007461) Platelets [#/volume] in Blood

1691

16607

1.24

1.67

52.6

27.2

269.71

247.05

e9/l

29.41

1676

16244

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

469

1.38

1.67

1.4

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

1691

16609

1.24

1.65

52.4

27.1

91.66

0.02

1684

16400

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

2.81

1.65

5.9

7.8

10.33

10.61

—

(3024932) HLA-DR beta [Type]

2.45

1.64

1.3

1.1

—

(3026361) Erythrocytes [#/volume] in Blood

1691

16611

1.24

1.63

52.5

27.1

4.37

4.40

e12/l

1.50

1675

16173

(3035941) MCH [Entitic mass]

1691

16611

1.24

1.63

52.4

27.0

30.12

30.41

8.47

1684

16401

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

1691

16611

1.24

1.63

53.6

27.6

39.51

39.61

0.37

1684

16393

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

294

1.47

1.63

1.5

1.2

—

(3000963) Hemoglobin [Mass/volume] in Blood

1691

16614

1.23

1.61

53.1

27.4

130.11

132.60

g/l

10.41

1684

16408

(3010813) Leukocytes [#/volume] in Blood

1691

16614

1.23

1.61

52.6

27.2

7.82

6.73

e9/l

41.63

1675

16178

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

2.01

1.59

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

3.01

1.58

1.7

2.0

17.57

17.55

umol/l

—

(3012516) Albumin [Mass/volume] in Urine

648

6009

1.12

1.56

3.5

35.55

47.52

mg/l

1.14

394

3752

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

432

1.38

1.56

2.8

3.4

327.44

1123.02

u/ml

0.65

397

(3019225) pH of Specimen

218

1873

1.19

1.56

4.6

7.38

7.36

2.08

172

1319

(3024471) HLA-A [Type]

2.28

1.55

1.1

1.0

—

(3002256) Pathology report gross observation

265

2317

1.17

1.54

1.4

1.3

—

(1761868) Lipid panel - Serum or Plasma

475

5196

0.88

1.54

3.3

3.5

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1529

14909

1.15

1.51

7.2

7.0

40.29

39.85

mmol/mol

1.23

1442

13726

(3017817) Protein [Mass] in Urine collected for unspecified duration

162

1.61

1.49

1.6

2.5

800.04

702.42

0.08

162

(40768793) Breast Pathology biopsy report

500

0.67

1.49

1.2

1.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.91

1.49

1.5

1.4

—

(3024869) Neuronal Ab [Presence] in Serum

2.51

1.45

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.51

1.45

1.0

1.1

—

(3045142) Bone marrow Pathology biopsy report

236

1.49

1.45

1.3

—

(40765089) Chromosome analysis panel - Blood by G-banded

3.13

1.44

1.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.92

1.44

1.4

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

212

1.52

1.43

2.0

2.3

—

(3019150) Specific gravity of Urine by Refractometry

424

3856

1.13

1.41

5.8

4.5

1.02

1.40

kg/l

0.50

312

2618

(3042111) Morphology [Interpretation] in Bone marrow Narrative

355

1.39

1.40

1.5

1.6

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.42

1.39

1.7

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

2.95

1.36

1.4

1.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

191

1.53

1.35

1.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.92

1.33

1.4

1.3

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

0.00

1.32

0.0

2.2

—

2.28

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

160

1.57

1.31

1.4

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

250

1.45

1.31

1.3

13.36

10.58

u/l

0.38

195

(3022689) Creatine [Moles/volume] in Urine

2.10

1.30

2.1

1.3

6.23

6.75

mmol/l

—

(3037121) Protein [Mass/volume] in Urine

650

1.27

1.30

2.7

3.0

1690.06

287.88

mg/l

0.75

257

(3030981) Hyaline casts [#/volume] in Urine by Automated count

176

1513

1.18

1.28

2.7

2.4

0.31

0.52

e6/l

1.03

171

1449

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

118

977

1.22

1.28

1.2

67.49

129.18

u/ml

2.00

363

(40761536) Microorganisms panel - Urine sediment

159

1355

1.19

1.28

5.9

4.4

—

(40768446) Kidney Pathology biopsy report

2.09

1.27

1.7

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.29

1.27

1.0

1.2

—

(4024509) Urine culture

109

897

1.23

1.26

2.0

—

(21494755) Public health laboratory ask at order entry panel

784

0.77

1.21

1.3

1.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

198

2258

0.86

1.20

4.9

5.3

36.51

33.22

3.75

142

1424

(21494434) Karyotype in Bone marrow

189

1.49

1.19

1.1

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.11

1.18

1.0

1.6

1.18

1.16

mmol/l

—

(3036071) Salmonella sp Ab [Titer] in Serum

2.00

1.12

1.0

1.1

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

1267

12294

1.10

1.11

47.2

23.5

328.18

331.22

g/l

26.53

1262

12226

(1761482) Bacteria [#/volume] in Urine by Culture

467

0.72

1.09

6.1

4.6

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

2.19

1.08

2.6

1.6

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

1.66

1.06

1.3

1.4

5.39

5.91

u/l

0.34

(3019832) Treponema pallidum Ab [Presence] in Serum

725

1.22

1.04

1.7

1.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

649

6127

1.09

1.04

4.2

7.26

8.65

mg/mmol

0.37

380

3717

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

482

1.27

1.04

1.9

1.8

9.74

3.94

mg/l

1.87

371

(3028717) Thiamine [Mass/volume] in Blood

2.28

1.03

1.0

1.3

57.40

66.45

ug/l

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.64

1.03

1.6

1.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

179

1.46

1.03

2.1

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

131

1123

1.18

1.03

1.4

1.3

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

130

1.54

1.02

2.6

1.8

—

(3036048) Francisella tularensis Ab [Titer] in Serum

2.00

1.00

1.1

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

2.18

0.98

1.0

1.7

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

433

1.28

0.97

2.1

2.0

4.52

3.89

iu/l

0.14

169

(3003694) ABO and Rh group [Type] in Blood

403

4343

0.91

0.97

1.3

1.4

—

(3001186) Copper [Moles/volume] in Serum or Plasma

1.95

0.97

2.0

1.0

15.61

16.56

umol/l

—

(4094501) Cardiovascular stress test using bicycle ergometer

452

1.27

0.96

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

501

0.75

0.96

2.4

1.8

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.69

0.95

1.1

1.2

—

(4133840) Spirometry

2.23

0.93

1.3

1.2

—

(44806420) Estimation of glomerular filtration rate

142

0.56

0.93

2.6

—

(3000330) Specific gravity of Urine by Test strip

961

0.82

0.93

4.9

3.6

1.02

ratio

0.03

880

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.75

0.90

1.5

2.3

0.66

0.61

mmol/l

1.36

(3011288) Drugs identified in Urine by Screen method Nominal

168

1.43

0.90

2.5

1.8

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

485

1.25

0.88

1.3

1.6

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.86

0.87

1.9

1.5

8.64

9.76

ug/l

—

(3044290) Cell count panel - Cerebral spinal fluid

327

1.29

0.84

1.2

1.4

—

(3016879) Cocaine [Presence] in Urine

223

1.35

0.82

2.0

1.5

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

105

1.53

0.81

1.0

1.1

34.00

25.79

u/l

0.35

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

130

1.47

0.81

1.8

1.2

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

366

1.26

0.79

1.3

1.4

7.31

50.16

e6/l

1.11

269

(3026692) Albumin [Mass/volume] in Peritoneal fluid

1.67

0.78

1.8

1.2

18.23

13.46

g/l

—

(3000093) Morphology [Interpretation] in Blood Narrative

165

1.40

0.77

1.0

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

725

1.18

0.76

1.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

1.52

0.75

2.0

1.2

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

369

1.25

0.75

1.4

1.5

1368.46

484.73

e6/l

0.36

291

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

193

2124

0.90

0.73

11.6

7.3

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

125

1.44

0.72

1.1

1.6

14.06

13.97

umol/l

0.02

115

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1.61

0.72

1.3

1.2

131.76

174.56

pmol/l

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.58

0.71

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.71

0.70

1.3

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

156

1402

1.12

0.69

1.6

1.8

1.76

1.53

1.25

135

1179

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.67

0.68

1.3

1.4

—

(4281824) Cell count and differential, peritoneal fluid

227

0.70

0.68

1.3

1.1

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

117

0.60

0.68

18.0

2.5

13.71

13.21

—

117

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1108

0.87

0.67

1.9

2.1

3.01

3.42

ratio

3.24

899

(3023183) Ammonium ion [Moles/volume] in Plasma

402

1.22

0.67

2.5

2.8

32.85

33.38

umol/l

0.06

356

(3032057) Clostridioides difficile [Presence] in Stool

1.63

0.67

2.6

1.7

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

179

0.67

0.66

1.3

1.5

1295.49

970.69

mu/l

—

152

(3006442) Creatine [Moles/volume] in Serum or Plasma

112

1.43

0.63

1.2

1.4

82.56

87.15

umol/l

0.22

112

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

370

0.78

0.63

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

102

0.59

0.62

1.2

1.4

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.64

0.62

1.0

1.7

82.88

650.43

nmol/24h

—

(3014891) Appearance of Pleural fluid

1.67

0.61

2.0

1.5

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.60

0.0

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.60

0.0

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

0.00

0.59

0.0

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

0.00

0.59

0.0

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.59

0.0

1.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

1.45

0.59

2.1

1.2

—

(3027944) Amphetamines [Presence] in Urine

237

1.27

0.58

1.8

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

1.46

0.58

1.2

1.0

—

(3024263) Appearance of Synovial fluid

1.46

0.58

1.9

1.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

184

1.31

0.58

2.0

1.8

9895.88

4857.06

u/l

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1542

15231

1.08

0.56

5.9

5.6

5.86

6.01

mmol/l

5.78

1433

13730

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.62

0.55

1.2

1.3

—

(3000764) Benzodiazepines [Presence] in Urine

239

1.26

0.55

2.0

1.5

—

(3027008) Opiates [Presence] in Urine

239

1.26

0.55

2.0

1.5

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

168

1.31

0.55

1.7

1.3

14936.91

97658.27

e6/l

1.15

110

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

169

1.31

0.53

1.2

1.1

2.34

2.24

eliau/ml

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

382

0.81

0.53

1.6

1.5

120.74

242.26

pmol/l

1.65

372

(3028300) Cannabinoids [Presence] in Urine

241

1.25

0.52

2.0

1.5

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.46

0.50

1.0

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.46

0.50

1.2

3.0

4.17

5.63

ug/l

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

401

3822

1.06

0.50

5.0

4.9

19.23

21.73

2.53

179

2037

(3039443) Prostate specific Ag panel - Serum or Plasma

199

0.75

0.46

1.1

1.8

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1469

14519

1.06

0.44

4.5

1.22

1.27

mmol/l

2.42

1331

13030

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

121

1.33

0.44

1.0

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

495

4766

1.05

0.44

5.7

6.0

2.25

4.41

ug/l

1.52

438

4257

(3047189) Immunofixation for 24 hour Urine

104

1.35

0.43

2.2

1.7

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.65

0.42

1.2

1.5

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

122

1.31

0.42

1.5

1.8

103.90

106.90

ng/l

0.05

122

(3019174) dRVVT (LA screen)

0.00

0.41

0.0

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

0.00

0.41

0.0

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.41

0.0

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

0.41

0.0

1.3

—

(4035726) Immunohistochemistry procedure

177

1654

1.08

0.41

1.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.39

0.40

1.3

1.7

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

0.40

0.0

1.2

—

(3022621) pH of Urine by Test strip

153

1425

1.08

0.39

3.2

3.0

6.12

6.08

0.14

989

(4146454) Self-monitoring of blood glucose

226

0.79

0.39

2.8

2.7

—

(3032773) Endomysium IgG Ab [Titer] in Serum

142

1.27

0.38

1.1

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

1.43

0.35

1.3

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.43

0.35

1.5

1.7

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

135

1.26

0.35

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

469

0.87

0.35

1.4

1.5

—

(3007566) Smooth muscle Ab [Titer] in Serum

471

1.13

0.34

1.2

368.00

100.83

titre

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.33

0.33

1.0

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

127

1.26

0.33

1.4

1.3

—

(4211845) Urine protein measurement

0.67

0.33

3.2

3.9

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.67

0.32

1.2

1.5

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

164

1.22

0.32

1.2

1.71

1.49

nmol/l

0.34

146

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.32

0.30

1.3

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

175

1.20

0.30

1.3

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

111

1.26

0.30

1.1

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

111

1.26

0.30

1.1

1.5

—

(4034850) Laboratory test

477

1.11

0.29

12.9

11.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.25

0.29

5.9

2.7

5.33

4.85

kpa

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.25

0.29

5.9

2.7

9.54

10.22

kpa

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

335

1.14

0.29

1.0

1.3

14.83

35.30

u/l

2.75

283

(3025130) Human papilloma virus identified in Specimen

167

1.20

0.28

1.8

1.9

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.27

0.27

1.4

1.3

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

140

1.22

0.27

1.0

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

321

0.87

0.26

1.3

1.4

0.85

0.79

nmol/l

0.27

268

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

113

1.24

0.26

1.1

13.92

10.39

nmol/l

—

(3044007) Cell count panel - Peritoneal fluid

1.19

0.26

2.8

1.8

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

367

1.12

0.26

1.4

1.3

3.82

3.78

mmol/l

0.13

349

(40765096) Chromosome analysis panel by Banding

1.23

0.25

1.4

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

1.25

0.24

1.1

1.0

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.27

0.24

1.6

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.27

0.24

1.6

1.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.73

0.24

1.5

1.6

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

106

1.23

0.23

2.0

1.8

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

136

0.81

0.23

1.0

43.83

44.49

ng/l

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

136

0.81

0.23

1.0

1015.50

692.84

ng/l

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.28

0.23

1.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

400

1.10

0.22

2.6

2.3

124.25

77.14

ug/min

0.40

229

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

381

1.10

0.22

1.9

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

135

0.81

0.22

1.0

306.00

322.41

ng/l

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

7.5

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

0.21

0.0

1.1

—

(40758358) Immune stain study

0.00

0.21

0.0

1.0

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.5

—

(3024316) Viscosity of Plasma

0.00

0.21

0.0

1.6

—

1.58

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

316

1.11

0.20

1.9

1.8

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.00

0.20

0.0

3.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.20

0.0

1.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.20

0.19

1.0

1.2

—

(3049717) Cytology report of Urine Cyto stain

724

1.07

0.19

2.1

2.5

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.15

0.19

1.0

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

147

1.16

0.18

1.2

2.2

1.18

1.81

u/field

0.50

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.17

0.17

1.3

1.0

—

(40768795) Lymph node Pathology biopsy report

195

1.13

0.17

1.4

1.2

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

804

0.94

0.17

1.9

1.8

3.26

3.50

mmol/l

1.10

601

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

0.75

0.17

1.0

2276.80

1594.12

miu/ml

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

748

1.06

0.17

2.3

3.3

86.42

5489.86

u/ml

0.85

644

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

1.14

0.16

1.5

1.3

6.00

6.34

mmol/l

—

(3006462) Nitrate [Presence] in Urine

0.75

0.15

3.2

4.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.14

0.15

1.0

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

772

1.05

0.14

2.1

1.8

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.19

0.14

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

180

0.89

0.13

1.3

1.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

364

1.07

0.13

5.3

3.6

32.71

26.16

mg/l

0.58

250

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

288

2824

1.02

0.12

3.6

3.5

0.58

0.79

ug/l

8.29

197

1980

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1561

15559

1.02

0.11

6.3

2.50

2.63

mmol/l

7.37

1456

14178

(3025577) Chromium [Mass/volume] in Blood

105

1.14

0.11

2.4

2.2

1.61

1.95

ug/l

0.45

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

1.11

0.09

1.0

1.2

6.80

10.80

mm/h

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.11

0.09

1.7

1.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

451

0.95

0.08

1.4

1.2

—

(40768800) Prostate Pathology biopsy report

351

1.06

0.08

1.2

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.77

0.08

1.0

1.1

347.20

230.51

iu/ml

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

127

1.10

0.08

1.5

1.3

—

(3004451) EKG impression Narrative

118

1.10

0.07

2.0

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.05

0.07

6.8

3.9

0.44

1.24

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1518

15146

1.01

0.06

5.4

5.3

1.52

1.49

mmol/l

2.47

1400

13756

(40768441) Liver Pathology biopsy report

138

1.09

0.06

1.0

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

703

1.03

0.05

2.0

1.8

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

225

2229

1.01

0.04

1.4

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1529

15270

1.01

0.03

5.5

5.4

4.46

4.57

mmol/l

4.00

1418

13977

(3006922) Hepatitis E virus Ab [Presence] in Serum

113

1.06

0.01

1.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

147

0.95

0.01

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

304

1.02

0.00

1.2

1.3

104.83

230.99

miu/ml

—

123

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

105

0.95

0.00

1.1

1.3

10.96

9.70

mmol/l

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

139

1.01

0.00

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

116

1.03

0.00

2.3

2.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

228

1.01

0.00

2.2

2.3

0.39

1.20

g/24h

2.11

129

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

263

0.99

0.00

1.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.0

3.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

5.2

—

376.60

—

(3033086) Enterovirus Ab [Titer] in Serum

0.00

0.0

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.6

—

2.90

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

0.0

1.0

—

169.00

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

0.0

5.6

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.0

1.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

247.60

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.4

—

2.63

—

(3006598) pH of Arterial cord blood

0.00

-0.00

0.0

1.0

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

0.89

-0.00

1.0

1.2

—

13.40

—

(3042517) Benzodiazepines panel - Urine

0.00

-0.00

0.0

1.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

-0.00

0.0

2.1

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.00

-0.00

0.0

1.0

—

7.61

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

250

1.00

-0.00

1.0

1.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.96

-0.00

2.1

1.6

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.88

-0.00

1.2

1.5

69.40

47.62

ug/l

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

-0.00

0.0

1.6

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

-0.00

0.0

1.0

—

2.94

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

-0.00

0.0

1.2

—

7.67

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

3.4

—

2.96

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

52.27

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

0.92

-0.00

1.0

1.2

—

(3020650) Glucose [Presence] in Urine

0.94

-0.00

1.0

2.0

0.00

0.05

estimate

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.5

—

397.00

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

0.90

-0.00

2.1

1.8

41.39

39.60

g/l

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

27.72

—

Mortality – FinRegistry

↥

Association

Association between endpoint ASTHMA_OPPORTUNIST_INFECTIONS and mortality.

Females

Parameter	HR [95% CI]	p-value
ASTHMA_OPPORTUNIST_INFECTIONS	1.696 [1.51, 1.91]	< 0.001
Birth year	0.994 [0.98, 1.01]	0.305

During the follow-up period (1.1.1998 — 31.12.2019), 996 out of 3792 females with ASTHMA_OPPORTUNIST_INFECTIONS died.

Males

Parameter	HR [95% CI]	p-value
ASTHMA_OPPORTUNIST_INFECTIONS	1.784 [1.56, 2.04]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.026

During the follow-up period (1.1.1998 — 31.12.2019), 952 out of 2501 males with ASTHMA_OPPORTUNIST_INFECTIONS died.

Mortality risk

Mortality risk for people of age

years, who have ASTHMA_OPPORTUNIST_INFECTIONS.

N-year risk	Females	Males
1	0.117%	0.382%
5	0.809%	2.183%
10	2.403%	5.354%
15	5.126%	10.554%
20	8.776%	16.998%

Relationships between endpoints

↥

Index endpoint: ASTHMA_OPPORTUNIST_INFECTIONS – Asthma and opportunity respiratory infection

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Asthma and opportunity respiratory infection

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints